Recent advances in lipid nanoparticles for delivery of nucleic acid, mRNA, and gene editing-based therapeutics
Lipid nanoparticles (LNPs) are becoming popular as a means of delivering therapeutics, including those based on nucleic acids and mRNA. The mRNA-based coronavirus disease 2019 vaccines are perfect examples to highlight the role played by drug delivery systems in advancing human health. The fundament...
Saved in:
Published in | Drug metabolism and pharmacokinetics Vol. 44; p. 100450 |
---|---|
Main Authors | , , , |
Format | Journal Article |
Language | English |
Published |
England
Elsevier Ltd
01.06.2022
The Japanese Society for the Study of Xenobiotics. Published by Elsevier Ltd |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Lipid nanoparticles (LNPs) are becoming popular as a means of delivering therapeutics, including those based on nucleic acids and mRNA. The mRNA-based coronavirus disease 2019 vaccines are perfect examples to highlight the role played by drug delivery systems in advancing human health. The fundamentals of LNPs for the delivery of nucleic acid- and mRNA-based therapeutics, are well established. Thus, future research on LNPs will focus on addressing the following: expanding the scope of drug delivery to different constituents of the human body, expanding the number of diseases that can be targeted, and studying the change in the pharmacokinetics of LNPs under physiological and pathological conditions. This review article provides an overview of recent advances aimed at expanding the application of LNPs, focusing on the pharmacokinetics and advantages of LNPs. In addition, analytical techniques, library construction and screening, rational design, active targeting, and applicability to gene editing therapy have also been discussed. |
---|---|
AbstractList | Lipid nanoparticles (LNPs) are becoming popular as a means of delivering therapeutics, including those based on nucleic acids and mRNA. The mRNA-based coronavirus disease 2019 vaccines are perfect examples to highlight the role played by drug delivery systems in advancing human health. The fundamentals of LNPs for the delivery of nucleic acid- and mRNA-based therapeutics, are well established. Thus, future research on LNPs will focus on addressing the following: expanding the scope of drug delivery to different constituents of the human body, expanding the number of diseases that can be targeted, and studying the change in the pharmacokinetics of LNPs under physiological and pathological conditions. This review article provides an overview of recent advances aimed at expanding the application of LNPs, focusing on the pharmacokinetics and advantages of LNPs. In addition, analytical techniques, library construction and screening, rational design, active targeting, and applicability to gene editing therapy have also been discussed.Lipid nanoparticles (LNPs) are becoming popular as a means of delivering therapeutics, including those based on nucleic acids and mRNA. The mRNA-based coronavirus disease 2019 vaccines are perfect examples to highlight the role played by drug delivery systems in advancing human health. The fundamentals of LNPs for the delivery of nucleic acid- and mRNA-based therapeutics, are well established. Thus, future research on LNPs will focus on addressing the following: expanding the scope of drug delivery to different constituents of the human body, expanding the number of diseases that can be targeted, and studying the change in the pharmacokinetics of LNPs under physiological and pathological conditions. This review article provides an overview of recent advances aimed at expanding the application of LNPs, focusing on the pharmacokinetics and advantages of LNPs. In addition, analytical techniques, library construction and screening, rational design, active targeting, and applicability to gene editing therapy have also been discussed. Lipid nanoparticles (LNPs) are becoming popular as a means of delivering therapeutics, including those based on nucleic acids and mRNA. The mRNA-based coronavirus disease 2019 vaccines are perfect examples to highlight the role played by drug delivery systems in advancing human health. The fundamentals of LNPs for the delivery of nucleic acid- and mRNA-based therapeutics, are well established. Thus, future research on LNPs will focus on addressing the following: expanding the scope of drug delivery to different constituents of the human body, expanding the number of diseases that can be targeted, and studying the change in the pharmacokinetics of LNPs under physiological and pathological conditions. This review article provides an overview of recent advances aimed at expanding the application of LNPs, focusing on the pharmacokinetics and advantages of LNPs. In addition, analytical techniques, library construction and screening, rational design, active targeting, and applicability to gene editing therapy have also been discussed. |
ArticleNumber | 100450 |
Author | Kato, Naoya Ogawa, Koki Mukai, Hidefumi Kawakami, Shigeru |
Author_xml | – sequence: 1 givenname: Hidefumi orcidid: 0000-0002-0749-8783 surname: Mukai fullname: Mukai, Hidefumi email: hmukai@nagasaki-u.ac.jp organization: Department of Pharmaceutical Informatics, Graduate School of Biomedical Sciences, Nagasaki University, 1-7-1 Sakamoto, Nagasaki-shi, Nagasaki, 852-8588, Japan – sequence: 2 givenname: Koki orcidid: 0000-0002-6248-0690 surname: Ogawa fullname: Ogawa, Koki organization: Department of Pharmaceutical Informatics, Graduate School of Biomedical Sciences, Nagasaki University, 1-7-1 Sakamoto, Nagasaki-shi, Nagasaki, 852-8588, Japan – sequence: 3 givenname: Naoya orcidid: 0000-0001-8233-5426 surname: Kato fullname: Kato, Naoya organization: Department of Pharmaceutical Informatics, Graduate School of Biomedical Sciences, Nagasaki University, 1-7-1 Sakamoto, Nagasaki-shi, Nagasaki, 852-8588, Japan – sequence: 4 givenname: Shigeru surname: Kawakami fullname: Kawakami, Shigeru email: skawakam@nagasaki-u.ac.jp organization: Department of Pharmaceutical Informatics, Graduate School of Biomedical Sciences, Nagasaki University, 1-7-1 Sakamoto, Nagasaki-shi, Nagasaki, 852-8588, Japan |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/35381574$$D View this record in MEDLINE/PubMed |
BookMark | eNp9UU1v1DAUtFAR_YA_wAH5yKFZ_BUnkRBSVQGtVIFUwdly7Oetl8QOdrJS_30dbamAQ0-2xjPz_GZO0VGIARB6S8mGEio_7DZ2nH5tGGGsAETU5AU6oW1LKtIxclTuXDSV4LI5Rqc57wjhvBbsFTrmNW9p3YgTFG7BQJixtnsdDGTsAx785C0OOsRJp9mbocAuJmxh8HtI9zg6HJYCe4O18fYcj7ffLs6xDhZvIQAG62cftlWvM1g830HSEyzFKb9GL50eMrx5PM_Qzy-ff1xeVTffv15fXtxUpmZ0rmQrhWCill0vpbOWatK1jnMJgtfOUUcbEFTr3lpdNmloJzvWcNczA9qwjp-hTwffaelHsOuKSQ9qSn7U6V5F7dW_L8HfqW3cq45LXpIpBu8fDVL8vUCe1eizgWHQAeKSFZOikbXgHSvUd3_PehryJ-RCYAeCSTHnBO6JQolam1Q7tTap1ibVockiav8TGT_r2cf1v354XvrxIIWS8N5DUtl4KO1an8DMykb_nPwBNtq6Zg |
CitedBy_id | crossref_primary_10_1007_s00005_023_00683_y crossref_primary_10_1016_j_ejps_2022_106239 crossref_primary_10_1016_j_amolm_2023_100005 crossref_primary_10_1016_j_ijpharm_2025_125367 crossref_primary_10_2745_dds_37_253 crossref_primary_10_1002_adhm_202401103 crossref_primary_10_1038_s43586_023_00200_7 crossref_primary_10_1016_j_xphs_2022_12_026 crossref_primary_10_37349_eemd_2024_00011 crossref_primary_10_3389_fimmu_2023_1116299 crossref_primary_10_3390_pathogens11121444 crossref_primary_10_1021_acsabm_2c00123 crossref_primary_10_3389_fgeed_2022_997142 crossref_primary_10_3390_ijms23105363 crossref_primary_10_1002_adma_202305099 crossref_primary_10_1016_j_jconrel_2022_05_042 crossref_primary_10_1080_10717544_2023_2191891 crossref_primary_10_1016_j_abst_2024_06_003 crossref_primary_10_1093_bjd_ljad528 crossref_primary_10_1002_btm2_10601 crossref_primary_10_1002_wnan_2007 crossref_primary_10_1007_s11051_024_06161_6 crossref_primary_10_1016_j_ijpharm_2024_124632 crossref_primary_10_1002_mco2_339 crossref_primary_10_35378_gujs_1325750 crossref_primary_10_1055_s_0042_1751036 crossref_primary_10_1080_17501911_2024_2430170 crossref_primary_10_1016_j_biomaterials_2024_122559 crossref_primary_10_1016_j_chest_2024_09_038 crossref_primary_10_3390_pharmaceutics14112357 crossref_primary_10_1021_acsnano_4c10154 crossref_primary_10_1016_j_toxlet_2023_07_011 crossref_primary_10_2147_IJN_S390866 crossref_primary_10_1007_s13346_024_01551_8 crossref_primary_10_3390_ph17050612 crossref_primary_10_1016_j_ejpb_2024_114468 crossref_primary_10_1055_s_0044_1791803 crossref_primary_10_1248_yakushi_22_00170_4 crossref_primary_10_3390_pharmaceutics16111366 crossref_primary_10_1002_btm2_10492 crossref_primary_10_1016_j_ijbiomac_2024_129581 crossref_primary_10_1016_j_omtn_2024_102424 crossref_primary_10_3390_gels9120953 crossref_primary_10_1021_acsbiomedchemau_4c00061 crossref_primary_10_2174_0122117385286781240228060152 crossref_primary_10_3390_pharmaceutics15031026 crossref_primary_10_3390_ijms26010110 crossref_primary_10_1007_s12274_024_6748_5 crossref_primary_10_1016_j_ijpharm_2023_122896 crossref_primary_10_3389_fmolb_2023_1128067 crossref_primary_10_1016_j_onano_2023_100132 |
Cites_doi | 10.1021/acsnano.7b04734 10.1021/acsnano.5b02796 10.1038/nbt.1602 10.1016/j.omtn.2019.01.013 10.1101/gad.1047403 10.1038/ncomms14630 10.1016/S0959-8049(02)00413-6 10.1126/science.aam9321 10.1002/adma.202006619 10.1126/sciadv.aba1028 10.1016/j.tips.2021.03.002 10.1073/pnas.1620874114 10.1016/j.ymthe.2019.02.012 10.1016/j.jconrel.2015.08.007 10.1126/sciimmunol.aaw6647 10.1016/j.addr.2018.03.008 10.1038/s41392-020-0207-x 10.1016/j.ymthe.2019.05.012 10.1126/sciadv.aba5672 10.1038/s41587-021-00933-4 10.1038/s41565-020-0737-y 10.1021/ac202028g 10.1038/s41565-020-0669-6 10.1038/mtna.2012.28 10.1126/sciadv.abf4398 10.1021/acs.accounts.9b00368 10.1021/acs.chemrev.9b00738 10.1002/adhm.201200431 10.1016/j.addr.2019.11.005 10.1002/adma.201904905 10.1016/j.jconrel.2019.10.028 10.1126/science.aaq1067 10.1038/s41591-018-0209-1 10.1126/science.1258096 10.1038/s41587-020-0565-5 10.1084/jem.189.12.1961 10.1021/acsinfecdis.9b00084 10.1038/nbt.1989 10.1016/j.jconrel.2014.02.014 10.1038/s41565-021-00928-x 10.1016/j.addr.2020.07.001 10.1073/pnas.1619653114 10.1126/science.aaf5573 10.1016/j.addr.2020.06.026 10.1002/jps.21024 10.1073/pnas.1031523100 10.1146/annurev-biochem-060713-035456 10.1021/acs.jpcb.7b10795 10.1021/acs.nanolett.8b03149 10.3390/ma9120994 10.1038/s41576-018-0059-1 10.1038/s41587-020-0491-6 10.1016/0092-8674(93)90305-A 10.1021/acs.nanolett.5b02497 10.1016/j.bmc.2010.11.033 10.1038/nrd.2016.280 10.1039/D0BM01609H 10.1073/pnas.87.15.5744 10.1002/adma.201606628 10.1016/j.addr.2020.06.002 10.1016/j.nucmedbio.2020.06.007 10.1016/j.cell.2021.02.030 10.1038/sj.gt.3301089 10.1021/la204833h 10.1038/sj.onc.1208219 10.1016/0092-8674(88)90162-6 10.1016/j.tibtech.2013.04.004 10.1038/s41591-018-0327-9 10.1038/s41587-021-00822-w 10.1073/pnas.0400187101 10.1021/jp303267y 10.1038/ncomms11856 10.1016/j.ijpharm.2021.120586 10.1016/j.biomaterials.2020.120282 10.1016/j.drudis.2013.10.011 10.1080/10717544.2018.1474964 10.1038/s41551-019-0378-3 10.1073/pnas.1117018109 10.1038/s41467-020-19156-3 10.1023/A:1007501122611 10.1248/cpb.53.871 10.1016/j.biomaterials.2012.02.033 10.1038/nbt.3471 10.1021/acs.molpharmaceut.8b01052 10.1016/j.celrep.2018.02.014 10.1021/acs.bioconjchem.0c00366 10.1016/j.jconrel.2020.03.006 10.1038/s41589-019-0285-7 10.1038/s41586-021-03534-y 10.1038/nature24049 10.1002/adma.201902575 10.1016/j.jconrel.2017.09.012 10.1038/mtna.2013.66 10.1039/C9NR05788A 10.1146/annurev-neuro-062012-170307 10.1038/nn.2467 10.1038/nature17946 10.2967/jnumed.110.081539 10.2967/jnumed.110.083949 10.1126/sciadv.abc9450 10.1016/j.ymthe.2017.03.013 10.1038/s41467-018-06936-1 10.1016/j.jconrel.2014.06.001 10.1073/pnas.1520244113 10.1016/S0939-6411(01)00165-5 10.1038/mt.2010.85 10.1016/S0378-5173(02)00129-1 10.1038/s41587-019-0325-6 10.1038/s41565-019-0591-y 10.1002/anie.201203263 10.1016/j.cell.2020.07.024 10.1016/j.cell.2012.01.002 10.1038/s41551-020-00671-z 10.1073/pnas.0910603106 10.1126/sciadv.abb4429 10.1038/sj.gt.3301460 10.1016/j.jconrel.2018.12.006 10.1002/adma.202007603 10.1021/mp800049w 10.1126/science.1232033 10.1021/acsnano.0c10064 10.1016/S0169-409X(99)00042-3 10.1007/s00228-003-0643-x 10.1038/s41565-017-0043-5 10.1248/bpb.b13-00059 10.1016/j.addr.2010.09.010 10.1073/pnas.2020401118 10.1615/CritRevTherDrugCarrierSyst.v19.i3.10 10.1126/science.1231143 10.1126/scitranslmed.aat9143 10.1038/s41467-020-17029-3 10.1039/C8NR09855G 10.1038/nm0498-467 10.1016/j.cobme.2018.08.001 10.1038/nprot.2013.143 10.1126/science.aaf8729 10.1073/pnas.0503123102 10.1126/science.aat5011 10.1016/j.addr.2010.09.001 |
ContentType | Journal Article |
Copyright | 2022 The Japanese Society for the Study of Xenobiotics Copyright © 2022 The Japanese Society for the Study of Xenobiotics. Published by Elsevier Ltd. All rights reserved. 2022 The Japanese Society for the Study of Xenobiotics. Published by Elsevier Ltd. All rights reserved. 2022 The Japanese Society for the Study of Xenobiotics |
Copyright_xml | – notice: 2022 The Japanese Society for the Study of Xenobiotics – notice: Copyright © 2022 The Japanese Society for the Study of Xenobiotics. Published by Elsevier Ltd. All rights reserved. – notice: 2022 The Japanese Society for the Study of Xenobiotics. Published by Elsevier Ltd. All rights reserved. 2022 The Japanese Society for the Study of Xenobiotics |
DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM 7X8 5PM |
DOI | 10.1016/j.dmpk.2022.100450 |
DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic PubMed Central (Full Participant titles) |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic |
DatabaseTitleList | MEDLINE - Academic MEDLINE |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Pharmacy, Therapeutics, & Pharmacology |
EISSN | 1880-0920 |
EndPage | 100450 |
ExternalDocumentID | PMC9363157 35381574 10_1016_j_dmpk_2022_100450 S1347436722000076 |
Genre | Journal Article Review |
GroupedDBID | --- --M 0R~ 29G 2WC 4.4 457 53G 5GY 7-5 8P~ AACTN AAEDT AAEDW AAIAV AAIKJ AAKOC AALRI AAOAW AATCM AAXUO ABJNI ABMAC ABXDB ABYKQ ACDAQ ACGFO ACGFS ACRLP ADBBV ADEZE AEBSH AEKER AENEX AFKWA AFTJW AFXIZ AGHFR AGUBO AIEXJ AIKHN AITUG AJBFU AJOXV ALMA_UNASSIGNED_HOLDINGS AMFUW AMRAJ AXJTR BAWUL BKOJK BKOMP BLXMC CS3 DIK DU5 E3Z EBS EFJIC EFLBG EJD F5P FDB FEDTE FIRID FYGXN GBLVA GX1 HH5 HVGLF HZ~ JMI JSF JSH KOM KQ8 M41 MOJWN M~E O9- OAUVE RJT RNS ROL RZJ SPCBC SSP SSZ T5K TKC TR2 ~G- AAQFI AATTM AAXKI AAYWO AAYXX ACVFH ADCNI AEIPS AEUPX AFJKZ AFPUW AGCQF AGRNS AIGII AIIUN AKBMS AKRWK AKYEP ANKPU APXCP BNPGV CITATION OVT SSH CGR CUY CVF ECM EFKBS EIF NPM 7X8 5PM |
ID | FETCH-LOGICAL-c521t-6864424569b66fdd1a098f336e435ff1f17e41aabdda38171969273fb2ceac293 |
IEDL.DBID | AIKHN |
ISSN | 1347-4367 1880-0920 |
IngestDate | Thu Aug 21 18:19:59 EDT 2025 Thu Jul 10 23:10:44 EDT 2025 Mon Jul 21 06:03:38 EDT 2025 Tue Jul 01 03:08:32 EDT 2025 Thu Apr 24 23:04:34 EDT 2025 Fri Feb 23 02:41:24 EST 2024 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Keywords | Recombination Targeting DNA barcode Gene editing Base editing mRNA Ionizable lipid Positron emission tomography Lipid nanoparticle Nucleic acid |
Language | English |
License | Copyright © 2022 The Japanese Society for the Study of Xenobiotics. Published by Elsevier Ltd. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c521t-6864424569b66fdd1a098f336e435ff1f17e41aabdda38171969273fb2ceac293 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 ObjectType-Review-3 content type line 23 Contributed equally to this work. |
ORCID | 0000-0002-6248-0690 0000-0002-0749-8783 0000-0001-8233-5426 |
OpenAccessLink | https://pubmed.ncbi.nlm.nih.gov/PMC9363157 |
PMID | 35381574 |
PQID | 2647654392 |
PQPubID | 23479 |
PageCount | 1 |
ParticipantIDs | pubmedcentral_primary_oai_pubmedcentral_nih_gov_9363157 proquest_miscellaneous_2647654392 pubmed_primary_35381574 crossref_primary_10_1016_j_dmpk_2022_100450 crossref_citationtrail_10_1016_j_dmpk_2022_100450 elsevier_sciencedirect_doi_10_1016_j_dmpk_2022_100450 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2022-06-01 |
PublicationDateYYYYMMDD | 2022-06-01 |
PublicationDate_xml | – month: 06 year: 2022 text: 2022-06-01 day: 01 |
PublicationDecade | 2020 |
PublicationPlace | England |
PublicationPlace_xml | – name: England |
PublicationTitle | Drug metabolism and pharmacokinetics |
PublicationTitleAlternate | Drug Metab Pharmacokinet |
PublicationYear | 2022 |
Publisher | Elsevier Ltd The Japanese Society for the Study of Xenobiotics. Published by Elsevier Ltd |
Publisher_xml | – name: Elsevier Ltd – name: The Japanese Society for the Study of Xenobiotics. Published by Elsevier Ltd |
References | Leung, Hafez, Baoukina, Belliveau, Zhigaltsev, Afshinmanesh (bib32) 2012; 116 Ma, Yang, Sun, Chen, Rui, Glass (bib48) 2020; 6 Levchenko, Rammohan, Lukyanov, Whiteman, Torchilin (bib83) 2002; 240 Maruyama, Ishida, Takizawa, Moribe (bib93) 1999; 40 Kedmi, Veiga, Ramishetti, Goldsmith, Rosenblum, Dammes (bib77) 2018; 13 Kauffman, Dorkin, Yang, Heartlein, Derosa, Mir (bib20) 2015; 15 Yamaguchi, Yu, Inouye (bib94) 1988; 53 Sebastiani, Yanez Arteta, Lerche, Porcar, Lang, Bragg (bib44) 2021; 15 Lokugamage, Sago, Dahlman (bib68) 2018; 7 Tanaka, Sakurai, Anindita, Akita (bib17) 2020; 154–155 Gaj, Gersbach, Barbas (bib103) 2013; 31 Sakurai, Nishioka, Yamashita, Takakura, Hashida (bib40) 2001; 52 Lindsay, Bhosle, Zurla, Beyersdorf, Rogers, Vanover (bib66) 2019; 3 Sago, Lokugamage, Lando, Djeddar, Shah, Syed (bib72) 2018; 18 Zhang, El-Mayta, Murdoch, Warzecha, Billingsley, Shepherd (bib69) 2021; 9 Hewitt, Bai, Bailey, Ichikawa, Zielinski, Karp (bib140) 2019; 11 Rees, Liu (bib107) 2018; 19 Rybakova, Kowalski, Huang, Gonzalez, Heartlein, DeRosa (bib138) 2019; 27 Kress, Wurdack, Zimmer, Weigt, Janzen (bib74) 2005; 102 Park, Hong, Kirpotin, Colbern, Shalaby, Baselga (bib91) 2002; 8 Massoud, Gambhir (bib33) 2003; 17 Schoenmaker, Witzigmann, Kulkarni, Verbeke, Kersten, Jiskoot (bib10) 2021; 601 Tavitian, Terrazzino, Kühnast, Marzabal, Stettler, Dollé (bib62) 1998; 4 Yin, Kauffman, Anderson (bib110) 2017; 16 Finn, Smith, Patel, Shaw, Youniss, van Heteren (bib116) 2018; 22 Witzigmann, Kulkarni, Leung, Chen, Cullis, van der Meel (bib8) 2020; 159 Nishida, Arazoe, Yachie, Banno, Kakimoto, Tabata (bib109) 2016; 353 Wei, Cheng, Min, Olson, Siegwart (bib120) 2020; 11 Pardi, Secreto, Shan, Debonera, Glover, Yi (bib136) 2017; 8 Viger-Gravel, Schantz, Pinon, Rossini, Schantz, Emsley (bib31) 2018; 122 Liu, Chang, Jiang, Meng, Sun, Mao (bib117) 2019; 31 Abudayyeh, Gootenberg, Essletzbichler, Han, Joung, Belanto (bib134) 2017; 550 Mali, Yang, Esvelt, Aach, Guell, DiCarlo (bib102) 2013; 339 Akinc, Maier, Manoharan, Fitzgerald, Jayaraman, Barros (bib25) 2019; 14 Akinc, Querbes, De, Qin, Frank-Kamenetsky, Jayaprakash (bib38) 2010; 18 Wei, Rosenkrans, Liu, Huang, Luo, Cai (bib58) 2020; 120 Ran, Hsu, Wright, Agarwala, Scott, Zhang (bib104) 2013; 8 Chen, Ganesh, Wang, Amiji (bib42) 2019; 11 Cheng, Wei, Farbiak, Johnson, Dilliard, Siegwart (bib47) 2020; 15 Zhang, Li, Deng, Zhao, Huang, Yang (bib35) 2020; 182 Mukai, Ozaki, Cui, Kuboyama, Yamato-Nagata, Onoe (bib64) 2014; 180 Ramishetti, Hazan-Halevy, Palakuri, Chatterjee, Gonna, Dammes (bib80) 2020; 32 Lino, Harper, Carney, Timlin (bib112) 2018; 25 Kose, Fox, Sapparapu, Bombardi, Tennekoon, Dharshan De Silva (bib137) 2019; 4 Cullis, Hope (bib1) 2017; 25 Mukai, Hatanaka, Yagi, Warashina, Zouda, Takahashi (bib65) 2019; 294 Yin, Song, Dorkin, Zhu, Li, Wu (bib124) 2016; 34 Knott, Doudna (bib106) 2018; 361 Rothgangl, Dennis, Lin, Oka, Witzigmann, Villiger (bib129) 2021; 39 Hu, Zhong, Weng, Peng, Huang, Zhao (bib5) 2020; 5 Kretzschmar, Watt (bib51) 2012; 148 Gaudelli, Lam, Rees, Solá-Esteves, Barrera, Born (bib128) 2020; 38 Maeder, Stefanidakis, Wilson, Baral, Barrera, Bounoutas (bib105) 2019; 25 Iwano, Sugiyama, Hama, Watakabe, Hasegawa, Kuchimaru (bib37) 2018; 359 Sakai, Passioura, Sato, Ito, Furuhashi, Umitsu (bib59) 2019; 15 Ramaswamy, Tonnu, Tachikawa, Limphong, Vega, Karmali (bib26) 2017; 114 Takashima, Yokoyama, Mizuma, Yamanaka, Wada, Onoe (bib57) 2011; 52 Francia, Schiffelers, Cullis, Witzigmann (bib46) 2020; 31 Semple, Akinc, Chen, Sandhu, Mui, Cho (bib11) 2010; 28 Patel, Ibrahim, Cheng (bib13) 2021; 42 Gupta, Price, Aboagye (bib53) 2002; 38 Farbiak, Cheng, Wei, Álvarez-Benedicto, Johnson, Lee (bib125) 2021; 33 Blanchard, Vanover, Bawage, Tiwari, Rotolo, Beyersdorf (bib135) 2021; 39 Mukai, Watanabe (bib61) 2021; 92 Villiger, Rothgangl, Witzigmann, Oka, Lin, Qi (bib130) 2021 Feb 1; 5 Hatakeyama, Akita, Harashima (bib21) 2011; 63 Wang, Zuris, Meng, Rees, Sun, Deng (bib119) 2016; 113 Hassett, Benenato, Jacquinet, Lee, Woods, Yuzhakov (bib15) 2019; 15 Arteta, Kjellman, Bartesaghi, Wallin, Wu, Kvist (bib30) 2018; 115 Dammes, Goldsmith, Ramishetti, Dearling, Veiga, Packard (bib79) 2021; 16 Abudayyeh, Gootenberg, Konermann, Joung, Slaymaker, Cox (bib133) 2016; 353 Veiga, Goldsmith, Granot, Rosenblum, Dammes, Kedmi (bib78) 2018; 9 Cong, Ran, Cox, Lin, Barretto, Habib (bib101) 2013; 339 Komor, Kim, Packer, Zuris, Liu (bib108) 2016; 533 Sakurai, Nishioka, Saito, Baba, Okuda, Matsumoto (bib39) 2001; 8 Akita, Ishiba, Hatakeyama, Tanaka, Sato, Tange (bib16) 2013; 2 Hindson, Ness, Masquelier, Belgrader, Heredia, Makarewicz (bib75) 2011; 83 Riley, Kashyap, Billingsley, White, Alameh, Bose (bib142) 2021; 7 Josephson, Ricardo, Szostak (bib99) 2014; 19 Nguyen, Roth, Li, Chen, Apathy, Mamedov (bib126) 2020; 38 Gebre, Brito, Tostanoski, Edwards, Carfi, Barouch (bib7) 2021; 184 Jain, Kesharwani, Gupta, Jain (bib89) 2012; 33 Winkles, Alberts (bib123) 2005; 24 Guimaraes, Zhang, Spektor, Tan, Chung, Billingsley (bib70) 2019; 316 Ramishetti, Kedmi, Goldsmith, Leonard, Sprague, Godin (bib81) 2015; 9 Kawakami, Higuchi, Hashida (bib88) 2008; 97 Harvey, Georgiou, Hayhurst, Jeong, Iverson, Rogers (bib95) 2004; 101 Madisen, Zwingman, Sunkin, Oh, Zariwala, Gu (bib50) 2010; 13 Hashida, Kawakami, Yamashita (bib84) 2005; 53 Doudna, Charpentier (bib100) 2014; 346 Musunuru, Chadwick, Mizoguchi, Garcia, DeNizio, Reiss (bib127) 2021; 593 Choe, Durgannavar, Chung (bib97) 2016; 9 Shin, Shukla, Chung, Beiss, Chan, Ortega-Rivera (bib6) 2020; 15 Sun, Zhou, Qiu, Shen (bib23) 2017; 29 Kulkarni, Witzigmann, Chen, Cullis, Van Der Meel (bib3) 2019; 52 Kuchimaru, Iwano, Kiyama, Mitsumata, Kadonosono, Niwa (bib36) 2016; 7 Schoch, Seifert, Huhndorf, Robert, Spouge, Levesque (bib73) 2012; 109 Maruyama, Kennel, Huang (bib92) 1990; 87 Jiang, Park, Yin, Laureano, Jacquinet, Yang (bib141) 2020; 11 Kawakami, Nishikawa, Yamashita, Hashida (bib86) 2000; 17 Goswami, Chatzikleanthous, Lou, Giusti, Bonci, Taccone (bib76) 2019; 5 Mui, Tam, Jayaraman, Ansell, Du, Lin (bib24) 2013; 2 Maeki, Kimura, Sato, Harashima, Tokeshi (bib29) 2018; 128 Lokugamage, Gan, Zurla, Levin, Islam, Kalathoor (bib143) 2020; 32 Belliveau, Huft, Lin, Chen, Leung, Leaver (bib27) 2012; 1 Gootenberg, Abudayyeh, Lee, Essletzbichler, Dy, Joung (bib132) 2017; 356 Kawakami, Sato, Nishikawa, Yamashita, Hashida (bib85) 2000; 7 Rosenblum, Gutkin, Kedmi, Ramishetti, Veiga, Jacobi (bib121) 2020; 6 Kim, Jeong, Hur, Cho, Park, Jung (bib49) 2021; 7 Josh Huang, Zeng (bib52) 2013; 36 Kawakami, Hashida (bib87) 2014; 190 Hou, Zaks, Langer, Dong (bib2) 2021 Leuschner, Dutta, Gorbatov, Novobrantseva, Donahoe, Courties (bib19) 2011; 29 Hatakeyama, Akita, Harashima (bib22) 2013; 36 Sato, Kinami, Hashiba, Harashima (bib45) 2020; 322 Opanasopit, Nishikawa, Hashida (bib41) 2002; 19 Dahlman, Kauffman, Xing, Shaw, Mir, Dlott (bib67) 2017; 114 Paunovska, Da Silva Sanchez, Sago, Gan, Lokugamage, Islam (bib71) 2019; 31 Passioura, Katoh, Goto, Suga (bib98) 2014; 83 Qiu, Glass, Chen, Haas, Jin, Zhao (bib118) 2021; 118 Kowalski, Rudra, Miao, Anderson (bib9) 2019; 27 Ren, Mohri, Warashina, Wada, Watanabe, Mukai (bib60) 2019; 16 Kuboyama, Nakahara, Yoshino, Cui, Sako, Wada (bib63) 2011; 19 Liu, Erikson (bib122) 2003; 100 Zhigaltsev, Belliveau, Hafez, Leung, Huft, Hansen (bib28) 2012; 28 Xu, Chen, Luo, Zhang, Zhao, Lu (bib115) 2021; 168 Wang, Tiruthani, Li, Hu, Zhong, Tang (bib139) 2021; 33 Chen, Parayath, Ganesh, Wang, Amiji (bib43) 2019; 11 Mashel, Tarakanchikova, Muslimov, Zyuzin, Timin, Lepik (bib114) 2020; 258 Love, Mahon, Levins, Whitehead, Querbes, Dorkin (bib18) 2010; 107 Sugiyama, Yamashita (bib54) 2011; 63 Li, Huang (bib82) 2008; 5 Pardi, Tuyishime, Muramatsu, Kariko, Mui, Tam (bib34) 2015; 217 Liu, Zhang, Liu, Cheng (bib113) 2017; 266 Berlin, Berg, Briskin, Andrew, Kilshaw, Holzmann (bib96) 1993; 74 Samaridou, Heyes, Lutwyche (bib4) 2020; 154–155 Jayaraman, Ansell, Mui, Tam, Chen, Du (bib14) 2012; 51 Yamashita, Takashima, Kataoka, Oh, Sakuma, Takahashi (bib56) 2011; 52 Rietwyk, Peer (bib12) 2017; 11 van Haasteren, Li, Scheideler, Murthy, Schaffer (bib111) 2020; 38 Bergström, Grahnén, Långström (bib55) 2003; 59 Linehan, Martínez-Pomares, Stahl, Gordon (bib90) 1999; 189 Villiger, Grisch-Chan, Lindsay, Ringnalda, Pogliano, Allegri (bib131) 2018; 24 Paunovska, da Silva Sanchez, Foster, Loughrey, Blanchard, Islam (bib144) 2020; 6 Sakurai (10.1016/j.dmpk.2022.100450_bib39) 2001; 8 Sakai (10.1016/j.dmpk.2022.100450_bib59) 2019; 15 Liu (10.1016/j.dmpk.2022.100450_bib117) 2019; 31 Rybakova (10.1016/j.dmpk.2022.100450_bib138) 2019; 27 Abudayyeh (10.1016/j.dmpk.2022.100450_bib133) 2016; 353 Tavitian (10.1016/j.dmpk.2022.100450_bib62) 1998; 4 Passioura (10.1016/j.dmpk.2022.100450_bib98) 2014; 83 Semple (10.1016/j.dmpk.2022.100450_bib11) 2010; 28 van Haasteren (10.1016/j.dmpk.2022.100450_bib111) 2020; 38 Yamashita (10.1016/j.dmpk.2022.100450_bib56) 2011; 52 Opanasopit (10.1016/j.dmpk.2022.100450_bib41) 2002; 19 Maruyama (10.1016/j.dmpk.2022.100450_bib92) 1990; 87 Mali (10.1016/j.dmpk.2022.100450_bib102) 2013; 339 Choe (10.1016/j.dmpk.2022.100450_bib97) 2016; 9 Takashima (10.1016/j.dmpk.2022.100450_bib57) 2011; 52 Leung (10.1016/j.dmpk.2022.100450_bib32) 2012; 116 Hindson (10.1016/j.dmpk.2022.100450_bib75) 2011; 83 Mukai (10.1016/j.dmpk.2022.100450_bib61) 2021; 92 Hatakeyama (10.1016/j.dmpk.2022.100450_bib22) 2013; 36 Abudayyeh (10.1016/j.dmpk.2022.100450_bib134) 2017; 550 Lino (10.1016/j.dmpk.2022.100450_bib112) 2018; 25 Paunovska (10.1016/j.dmpk.2022.100450_bib71) 2019; 31 Akinc (10.1016/j.dmpk.2022.100450_bib25) 2019; 14 Gupta (10.1016/j.dmpk.2022.100450_bib53) 2002; 38 Josh Huang (10.1016/j.dmpk.2022.100450_bib52) 2013; 36 Knott (10.1016/j.dmpk.2022.100450_bib106) 2018; 361 Leuschner (10.1016/j.dmpk.2022.100450_bib19) 2011; 29 Kedmi (10.1016/j.dmpk.2022.100450_bib77) 2018; 13 Qiu (10.1016/j.dmpk.2022.100450_bib118) 2021; 118 Kowalski (10.1016/j.dmpk.2022.100450_bib9) 2019; 27 Arteta (10.1016/j.dmpk.2022.100450_bib30) 2018; 115 Schoch (10.1016/j.dmpk.2022.100450_bib73) 2012; 109 Yin (10.1016/j.dmpk.2022.100450_bib110) 2017; 16 Ma (10.1016/j.dmpk.2022.100450_bib48) 2020; 6 Kawakami (10.1016/j.dmpk.2022.100450_bib87) 2014; 190 Rosenblum (10.1016/j.dmpk.2022.100450_bib121) 2020; 6 Jiang (10.1016/j.dmpk.2022.100450_bib141) 2020; 11 Akita (10.1016/j.dmpk.2022.100450_bib16) 2013; 2 Farbiak (10.1016/j.dmpk.2022.100450_bib125) 2021; 33 Wang (10.1016/j.dmpk.2022.100450_bib119) 2016; 113 Kress (10.1016/j.dmpk.2022.100450_bib74) 2005; 102 Ramishetti (10.1016/j.dmpk.2022.100450_bib80) 2020; 32 Paunovska (10.1016/j.dmpk.2022.100450_bib144) 2020; 6 Cong (10.1016/j.dmpk.2022.100450_bib101) 2013; 339 Chen (10.1016/j.dmpk.2022.100450_bib43) 2019; 11 Wei (10.1016/j.dmpk.2022.100450_bib120) 2020; 11 Guimaraes (10.1016/j.dmpk.2022.100450_bib70) 2019; 316 Kose (10.1016/j.dmpk.2022.100450_bib137) 2019; 4 Schoenmaker (10.1016/j.dmpk.2022.100450_bib10) 2021; 601 Villiger (10.1016/j.dmpk.2022.100450_bib131) 2018; 24 Kulkarni (10.1016/j.dmpk.2022.100450_bib3) 2019; 52 Lokugamage (10.1016/j.dmpk.2022.100450_bib143) 2020; 32 Doudna (10.1016/j.dmpk.2022.100450_bib100) 2014; 346 Mashel (10.1016/j.dmpk.2022.100450_bib114) 2020; 258 Samaridou (10.1016/j.dmpk.2022.100450_bib4) 2020; 154–155 Tanaka (10.1016/j.dmpk.2022.100450_bib17) 2020; 154–155 Dammes (10.1016/j.dmpk.2022.100450_bib79) 2021; 16 Riley (10.1016/j.dmpk.2022.100450_bib142) 2021; 7 Sugiyama (10.1016/j.dmpk.2022.100450_bib54) 2011; 63 Maeder (10.1016/j.dmpk.2022.100450_bib105) 2019; 25 Kim (10.1016/j.dmpk.2022.100450_bib49) 2021; 7 Harvey (10.1016/j.dmpk.2022.100450_bib95) 2004; 101 Gaj (10.1016/j.dmpk.2022.100450_bib103) 2013; 31 Kawakami (10.1016/j.dmpk.2022.100450_bib85) 2000; 7 Wang (10.1016/j.dmpk.2022.100450_bib139) 2021; 33 Bergström (10.1016/j.dmpk.2022.100450_bib55) 2003; 59 Ren (10.1016/j.dmpk.2022.100450_bib60) 2019; 16 Dahlman (10.1016/j.dmpk.2022.100450_bib67) 2017; 114 Berlin (10.1016/j.dmpk.2022.100450_bib96) 1993; 74 Patel (10.1016/j.dmpk.2022.100450_bib13) 2021; 42 Love (10.1016/j.dmpk.2022.100450_bib18) 2010; 107 Kuchimaru (10.1016/j.dmpk.2022.100450_bib36) 2016; 7 Maruyama (10.1016/j.dmpk.2022.100450_bib93) 1999; 40 Ramishetti (10.1016/j.dmpk.2022.100450_bib81) 2015; 9 Viger-Gravel (10.1016/j.dmpk.2022.100450_bib31) 2018; 122 Mukai (10.1016/j.dmpk.2022.100450_bib64) 2014; 180 Finn (10.1016/j.dmpk.2022.100450_bib116) 2018; 22 Iwano (10.1016/j.dmpk.2022.100450_bib37) 2018; 359 Sakurai (10.1016/j.dmpk.2022.100450_bib40) 2001; 52 Kretzschmar (10.1016/j.dmpk.2022.100450_bib51) 2012; 148 Xu (10.1016/j.dmpk.2022.100450_bib115) 2021; 168 Sago (10.1016/j.dmpk.2022.100450_bib72) 2018; 18 Rees (10.1016/j.dmpk.2022.100450_bib107) 2018; 19 Park (10.1016/j.dmpk.2022.100450_bib91) 2002; 8 Gebre (10.1016/j.dmpk.2022.100450_bib7) 2021; 184 Linehan (10.1016/j.dmpk.2022.100450_bib90) 1999; 189 Ramaswamy (10.1016/j.dmpk.2022.100450_bib26) 2017; 114 Villiger (10.1016/j.dmpk.2022.100450_bib130) 2021; 5 Shin (10.1016/j.dmpk.2022.100450_bib6) 2020; 15 Hashida (10.1016/j.dmpk.2022.100450_bib84) 2005; 53 Zhigaltsev (10.1016/j.dmpk.2022.100450_bib28) 2012; 28 Jain (10.1016/j.dmpk.2022.100450_bib89) 2012; 33 Rietwyk (10.1016/j.dmpk.2022.100450_bib12) 2017; 11 Blanchard (10.1016/j.dmpk.2022.100450_bib135) 2021; 39 Francia (10.1016/j.dmpk.2022.100450_bib46) 2020; 31 Veiga (10.1016/j.dmpk.2022.100450_bib78) 2018; 9 Kawakami (10.1016/j.dmpk.2022.100450_bib88) 2008; 97 Hu (10.1016/j.dmpk.2022.100450_bib5) 2020; 5 Yamaguchi (10.1016/j.dmpk.2022.100450_bib94) 1988; 53 Mukai (10.1016/j.dmpk.2022.100450_bib65) 2019; 294 Zhang (10.1016/j.dmpk.2022.100450_bib69) 2021; 9 Rothgangl (10.1016/j.dmpk.2022.100450_bib129) 2021; 39 Akinc (10.1016/j.dmpk.2022.100450_bib38) 2010; 18 Lindsay (10.1016/j.dmpk.2022.100450_bib66) 2019; 3 Cullis (10.1016/j.dmpk.2022.100450_bib1) 2017; 25 Gootenberg (10.1016/j.dmpk.2022.100450_bib132) 2017; 356 Goswami (10.1016/j.dmpk.2022.100450_bib76) 2019; 5 Hewitt (10.1016/j.dmpk.2022.100450_bib140) 2019; 11 Sun (10.1016/j.dmpk.2022.100450_bib23) 2017; 29 Hatakeyama (10.1016/j.dmpk.2022.100450_bib21) 2011; 63 Sato (10.1016/j.dmpk.2022.100450_bib45) 2020; 322 Lokugamage (10.1016/j.dmpk.2022.100450_bib68) 2018; 7 Komor (10.1016/j.dmpk.2022.100450_bib108) 2016; 533 Hassett (10.1016/j.dmpk.2022.100450_bib15) 2019; 15 Zhang (10.1016/j.dmpk.2022.100450_bib35) 2020; 182 Belliveau (10.1016/j.dmpk.2022.100450_bib27) 2012; 1 Levchenko (10.1016/j.dmpk.2022.100450_bib83) 2002; 240 Pardi (10.1016/j.dmpk.2022.100450_bib34) 2015; 217 Maeki (10.1016/j.dmpk.2022.100450_bib29) 2018; 128 Mui (10.1016/j.dmpk.2022.100450_bib24) 2013; 2 Kawakami (10.1016/j.dmpk.2022.100450_bib86) 2000; 17 Massoud (10.1016/j.dmpk.2022.100450_bib33) 2003; 17 Liu (10.1016/j.dmpk.2022.100450_bib113) 2017; 266 Cheng (10.1016/j.dmpk.2022.100450_bib47) 2020; 15 Madisen (10.1016/j.dmpk.2022.100450_bib50) 2010; 13 Winkles (10.1016/j.dmpk.2022.100450_bib123) 2005; 24 Pardi (10.1016/j.dmpk.2022.100450_bib136) 2017; 8 Wei (10.1016/j.dmpk.2022.100450_bib58) 2020; 120 Yin (10.1016/j.dmpk.2022.100450_bib124) 2016; 34 Hou (10.1016/j.dmpk.2022.100450_bib2) 2021 Jayaraman (10.1016/j.dmpk.2022.100450_bib14) 2012; 51 Liu (10.1016/j.dmpk.2022.100450_bib122) 2003; 100 Nishida (10.1016/j.dmpk.2022.100450_bib109) 2016; 353 Chen (10.1016/j.dmpk.2022.100450_bib42) 2019; 11 Josephson (10.1016/j.dmpk.2022.100450_bib99) 2014; 19 Nguyen (10.1016/j.dmpk.2022.100450_bib126) 2020; 38 Musunuru (10.1016/j.dmpk.2022.100450_bib127) 2021; 593 Kuboyama (10.1016/j.dmpk.2022.100450_bib63) 2011; 19 Witzigmann (10.1016/j.dmpk.2022.100450_bib8) 2020; 159 Kauffman (10.1016/j.dmpk.2022.100450_bib20) 2015; 15 Gaudelli (10.1016/j.dmpk.2022.100450_bib128) 2020; 38 Li (10.1016/j.dmpk.2022.100450_bib82) 2008; 5 Sebastiani (10.1016/j.dmpk.2022.100450_bib44) 2021; 15 Ran (10.1016/j.dmpk.2022.100450_bib104) 2013; 8 |
References_xml | – start-page: 1 year: 2021 end-page: 17 ident: bib2 article-title: Lipid nanoparticles for mRNA delivery publication-title: Nat Rev Mater – volume: 6 year: 2020 ident: bib48 article-title: Neurotransmitter-derived lipidoids (NT-lipidoids) for enhanced brain delivery through intravenous injection publication-title: Sci Adv – volume: 115 start-page: E3351 year: 2018 end-page: E3360 ident: bib30 article-title: Successful reprogramming of cellular protein production through mRNA delivered by functionalized lipid nanoparticles publication-title: Proc Natl Acad Sci USA – volume: 7 start-page: 1 year: 2018 end-page: 8 ident: bib68 article-title: Testing thousands of nanoparticles in vivo using DNA barcodes publication-title: Curr Opin Biomed Eng – volume: 17 start-page: 545 year: 2003 end-page: 580 ident: bib33 article-title: Molecular imaging in living subjects: seeing fundamental biological processes in a new light publication-title: Genes Dev – volume: 9 start-page: 994 year: 2016 ident: bib97 article-title: Fc-binding ligands of immunoglobulin G: an overview of high affinity proteins and peptides publication-title: Materials – volume: 258 year: 2020 ident: bib114 article-title: Overcoming the delivery problem for therapeutic genome editing: current status and perspective of non-viral methods publication-title: Biomaterials – volume: 51 start-page: 8529 year: 2012 end-page: 8533 ident: bib14 article-title: Maximizing the potency of siRNA lipid nanoparticles for hepatic gene silencing in vivo publication-title: Angew Chem Int Ed Engl – volume: 2 start-page: 1120 year: 2013 end-page: 1125 ident: bib16 article-title: A neutral envelope-type nanoparticle containing pH-responsive and ss-cleavable lipid-like material as a carrier for plasmid DNA publication-title: Adv Healthc Mater – volume: 38 start-page: 845 year: 2020 end-page: 855 ident: bib111 article-title: The delivery challenge: fulfilling the promise of therapeutic genome editing publication-title: Nat Biotechnol – volume: 29 start-page: 1005 year: 2011 end-page: 1010 ident: bib19 article-title: Therapeutic siRNA silencing in inflammatory monocytes in mice publication-title: Nat Biotechnol – volume: 116 start-page: 18440 year: 2012 end-page: 18450 ident: bib32 article-title: Lipid nanoparticles containing siRNA synthesized by microfluidic mixing exhibit an electron-dense nanostructured core publication-title: J Phys Chem C Nanomater Interfaces – volume: 316 start-page: 404 year: 2019 end-page: 417 ident: bib70 article-title: Ionizable lipid nanoparticles encapsulating barcoded mRNA for accelerated in vivo delivery screening publication-title: J Contr Release – volume: 353 start-page: aaf8729 year: 2016 ident: bib109 article-title: Targeted nucleotide editing using hybrid prokaryotic and vertebrate adaptive immune systems publication-title: Science – volume: 31 start-page: 397 year: 2013 end-page: 405 ident: bib103 article-title: ZFN, TALEN, and CRISPR/Cas-based methods for genome engineering publication-title: Trends Biotechnol – volume: 593 start-page: 429 year: 2021 end-page: 434 ident: bib127 article-title: In vivo CRISPR base editing of PCSK9 durably lowers cholesterol in primates publication-title: Nature – volume: 15 start-page: 646 year: 2020 end-page: 655 ident: bib6 article-title: COVID-19 vaccine development and a potential nanomaterial path forward publication-title: Nat Nanotechnol – volume: 19 start-page: 388 year: 2014 end-page: 399 ident: bib99 article-title: mRNA display: from basic principles to macrocycle drug discovery publication-title: Drug Discov Today – volume: 25 start-page: 1467 year: 2017 end-page: 1475 ident: bib1 article-title: Lipid nanoparticle systems for enabling gene therapies publication-title: Mol Ther – volume: 52 start-page: 165 year: 2001 end-page: 172 ident: bib40 article-title: Effects of erythrocytes and serum proteins on lung accumulation of lipoplexes containing cholesterol or DOPE as a helper lipid in the single-pass rat lung perfusion system publication-title: Eur J Pharm Biopharm – volume: 33 year: 2021 ident: bib125 article-title: All-in-one dendrimer-based lipid nanoparticles enable precise HDR-mediated gene editing in vivo publication-title: Adv Mater – volume: 182 start-page: 1271 year: 2020 end-page: 1283 ident: bib35 article-title: A Thermostable mRNA vaccine against COVID-19 publication-title: Cell – volume: 5 start-page: 179 year: 2021 Feb 1 end-page: 189 ident: bib130 article-title: In vivo cytidine base editing of hepatocytes without detectable off-target mutations in RNA and DNA publication-title: Nat Biomed Eng – volume: 190 start-page: 542 year: 2014 end-page: 555 ident: bib87 article-title: Glycosylation-mediated targeting of carriers publication-title: J Contr Release – volume: 83 start-page: 727 year: 2014 end-page: 752 ident: bib98 article-title: Selection-based discovery of druglike macrocyclic peptides publication-title: Annu Rev Biochem – volume: 28 start-page: 3633 year: 2012 end-page: 3640 ident: bib28 article-title: Bottom-up design and synthesis of limit size lipid nanoparticle systems with aqueous and triglyceride cores using millisecond microfluidic mixing publication-title: Langmuir – volume: 7 start-page: 292 year: 2000 end-page: 299 ident: bib85 article-title: Mannose receptor-mediated gene transfer into macrophages using novel mannosylated cationic liposomes publication-title: Gene Ther – volume: 122 start-page: 2073 year: 2018 end-page: 2081 ident: bib31 article-title: Structure of lipid nanoparticles containing siRNA or mRNA by dynamic nuclear polarization-enhanced NMR spectroscopy publication-title: J Phys Chem B – volume: 36 start-page: 892 year: 2013 end-page: 899 ident: bib22 article-title: The polyethyleneglycol dilemma: advantage and disadvantage of PEGylation of liposomes for systemic genes and nucleic acids delivery to tumors publication-title: Biol Pharm Bull – volume: 24 start-page: 260 year: 2005 end-page: 266 ident: bib123 article-title: Differential regulation of polo-like kinase 1, 2, 3, and 4 gene expression in mammalian cells and tissues publication-title: Oncogene – volume: 15 start-page: 6709 year: 2021 end-page: 6722 ident: bib44 article-title: Apolipoprotein E binding drives structural and compositional rearrangement of mRNA-containing lipid nanoparticles publication-title: ACS Nano – volume: 87 start-page: 5744 year: 1990 end-page: 5748 ident: bib92 article-title: Lipid composition is important for highly efficient target binding and retention of immunoliposomes publication-title: Proc Natl Acad Sci USA – volume: 2 start-page: e139 year: 2013 ident: bib24 article-title: Influence of polyethylene glycol lipid desorption rates on pharmacokinetics and pharmacodynamics of siRNA lipid nanoparticles publication-title: Mol Ther Nucleic Acids – volume: 240 start-page: 95 year: 2002 end-page: 102 ident: bib83 article-title: Liposome clearance in mice: the effect of a separate and combined presence of surface charge and polymer coating publication-title: Int J Pharm – volume: 39 start-page: 949 year: 2021 end-page: 957 ident: bib129 article-title: In vivo adenine base editing of PCSK9 in macaques reduces LDL cholesterol levels publication-title: Nat Biotechnol – volume: 7 year: 2021 ident: bib49 article-title: Engineered ionizable lipid nanoparticles for targeted delivery of RNA therapeutics into different types of cells in the liver publication-title: Sci Adv – volume: 8 start-page: 677 year: 2001 end-page: 686 ident: bib39 article-title: Interaction between DNA-cationic liposome complexes and erythrocytes is an important factor in systemic gene transfer via the intravenous route in mice: the role of the neutral helper lipid publication-title: Gene Ther – volume: 11 start-page: 18806 year: 2019 end-page: 18824 ident: bib43 article-title: The role of apolipoprotein- and vitronectin-enriched protein corona on lipid nanoparticles for- and vivo targeted delivery and transfection of oligonucleotides in murine tumor models publication-title: Nanoscale – volume: 113 start-page: 2868 year: 2016 end-page: 2873 ident: bib119 article-title: Efficient delivery of genome-editing proteins using bioreducible lipid nanoparticles publication-title: Proc Natl Acad Sci U S A – volume: 601 start-page: 120586 year: 2021 ident: bib10 article-title: mRNA-lipid nanoparticle COVID-19 vaccines: structure and stability publication-title: Int J Pharm – volume: 109 start-page: 6241 year: 2012 end-page: 6246 ident: bib73 article-title: Nuclear ribosomal internal transcribed spacer (ITS) region as a universal DNA barcode marker for Fungi publication-title: Proc Natl Acad Sci USA – volume: 189 start-page: 1961 year: 1999 end-page: 1972 ident: bib90 article-title: Mannose receptor and its putative ligands in normal murine lymphoid and nonlymphoid organs: in situ expression of mannose receptor by selected macrophages, endothelial cells, perivascular microglia, and mesangial cells, but not dendritic cells publication-title: J Exp Med – volume: 36 start-page: 183 year: 2013 end-page: 215 ident: bib52 article-title: Genetic approaches to neural circuits in the mouse publication-title: Annu Rev Neurosci – volume: 8 start-page: 2281 year: 2013 end-page: 2308 ident: bib104 article-title: Genome engineering using the CRISPR-Cas9 system publication-title: Nat Protoc – volume: 29 year: 2017 ident: bib23 article-title: Rational design of cancer nanomedicine: nanoproperty integration and synchronization publication-title: Adv Mater – volume: 217 start-page: 345 year: 2015 end-page: 351 ident: bib34 article-title: Expression kinetics of nucleoside-modified mRNA delivered in lipid nanoparticles to mice by various routes publication-title: J Contr Release – volume: 8 start-page: 1172 year: 2002 end-page: 1181 ident: bib91 article-title: Anti-HER2 immunoliposomes: enhanced efficacy attributable to targeted delivery publication-title: Clin Cancer Res – volume: 92 start-page: 156 year: 2021 end-page: 170 ident: bib61 article-title: Review: PET imaging with macro- and middle-sized molecular probes publication-title: Nucl Med Biol – volume: 7 year: 2021 ident: bib142 article-title: Ionizable lipid nanoparticles for in utero mRNA delivery publication-title: Sci Adv – volume: 15 start-page: 598 year: 2019 end-page: 606 ident: bib59 article-title: Macrocyclic peptide-based inhibition and imaging of hepatocyte growth factor publication-title: Nat Chem Biol – volume: 339 start-page: 823 year: 2013 end-page: 826 ident: bib102 article-title: RNA-guided human genome engineering via Cas9 publication-title: Science – volume: 322 start-page: 217 year: 2020 end-page: 226 ident: bib45 article-title: Different kinetics for the hepatic uptake of lipid nanoparticles between the apolipoprotein E/low density lipoprotein receptor and the N-acetyl-D-galactosamine/asialoglycoprotein receptor pathway publication-title: J Contr Release – volume: 180 start-page: 92 year: 2014 end-page: 99 ident: bib64 article-title: Quantitative evaluation of the improvement in the pharmacokinetics of a nucleic acid drug delivery system by dynamic PET imaging with publication-title: J Contr Release – volume: 53 start-page: 871 year: 2005 end-page: 880 ident: bib84 article-title: Lipid carrier systems for targeted drug and gene delivery publication-title: Chem Pharm Bull – volume: 25 start-page: 1234 year: 2018 end-page: 1257 ident: bib112 article-title: Delivering crispr: a review of the challenges and approaches publication-title: Drug Deliv – volume: 24 start-page: 1519 year: 2018 end-page: 1525 ident: bib131 article-title: Treatment of a metabolic liver disease by in vivo genome base editing in adult mice publication-title: Nat Med – volume: 128 start-page: 84 year: 2018 end-page: 100 ident: bib29 article-title: Advances in microfluidics for lipid nanoparticles and extracellular vesicles and applications in drug delivery systems publication-title: Adv Drug Deliv Rev – volume: 34 start-page: 328 year: 2016 end-page: 333 ident: bib124 article-title: Therapeutic genome editing by combined viral and non-viral delivery of CRISPR system components in vivo publication-title: Nat Biotechnol – volume: 11 start-page: 8760 year: 2019 end-page: 8775 ident: bib42 article-title: The role of surface chemistry in serum protein corona-mediated cellular delivery and gene silencing with lipid nanoparticles publication-title: Nanoscale – volume: 74 start-page: 185 year: 1993 end-page: 195 ident: bib96 article-title: α4β7 integrin mediates lymphocyte binding to the mucosal vascular addressin MAdCAM-1 publication-title: Cell – volume: 38 start-page: 2094 year: 2002 end-page: 2107 ident: bib53 article-title: PET for in vivo pharmacokinetic and pharmacodynamic measurements publication-title: Eur J Cancer – volume: 266 start-page: 17 year: 2017 end-page: 26 ident: bib113 article-title: Delivery strategies of the CRISPR-Cas9 gene-editing system for therapeutic applications publication-title: J Contr Release – volume: 3 start-page: 371 year: 2019 end-page: 380 ident: bib66 article-title: Visualization of early events in mRNA vaccine delivery in non-human primates via PET–CT and near-infrared imaging publication-title: Nat Biomed Eng – volume: 27 start-page: 710 year: 2019 end-page: 728 ident: bib9 article-title: Delivering the messenger: advances in technologies for therapeutic mRNA delivery publication-title: Mol Ther – volume: 31 year: 2019 ident: bib117 article-title: Fast and efficient CRISPR/Cas9 genome editing in vivo enabled by bioreducible lipid and messenger RNA nanoparticles publication-title: Adv Mater – volume: 9 start-page: 1449 year: 2021 end-page: 1463 ident: bib69 article-title: Helper lipid structure influences protein adsorption and delivery of lipid nanoparticles to spleen and liver publication-title: Biomater Sci – volume: 13 start-page: 214 year: 2018 end-page: 219 ident: bib77 article-title: A modular platform for targeted RNAi therapeutics publication-title: Nat Nanotechnol – volume: 27 start-page: 1415 year: 2019 end-page: 1423 ident: bib138 article-title: mRNA delivery for therapeutic anti-HER2 antibody expression in vivo publication-title: Mol Ther – volume: 294 start-page: 185 year: 2019 end-page: 194 ident: bib65 article-title: Pharmacokinetic evaluation of liposomal nanoparticle-encapsulated nucleic acid drug: a combined study of dynamic PET imaging and LC/MS/MS analysis publication-title: J Contr Release – volume: 4 start-page: 467 year: 1998 end-page: 471 ident: bib62 article-title: In vivo imaging of oligonucleotides with positron emission tomography publication-title: Nat Med – volume: 52 start-page: 249 year: 2011 end-page: 256 ident: bib56 article-title: PET imaging of the gastrointestinal absorption of orally administered drugs in conscious and anesthetized rats publication-title: J Nucl Med – volume: 13 start-page: 133 year: 2010 end-page: 140 ident: bib50 article-title: A robust and high-throughput Cre reporting and characterization system for the whole mouse brain publication-title: Nat Neurosci – volume: 31 year: 2019 ident: bib71 article-title: Nanoparticles containing oxidized cholesterol deliver mRNA to the liver microenvironment at clinically relevant doses publication-title: Adv Mater – volume: 168 start-page: 3 year: 2021 end-page: 29 ident: bib115 article-title: Rational designs of in vivo CRISPR-Cas delivery systems publication-title: Adv Drug Deliv Rev – volume: 550 start-page: 280 year: 2017 end-page: 284 ident: bib134 article-title: RNA targeting with CRISPR-Cas13 publication-title: Nature – volume: 184 start-page: 1589 year: 2021 end-page: 1603 ident: bib7 article-title: Novel approaches for vaccine development publication-title: Cell – volume: 11 start-page: 7572 year: 2017 end-page: 7586 ident: bib12 article-title: Next-generation lipids in RNA interference therapeutics publication-title: ACS Nano – volume: 15 start-page: 313 year: 2020 end-page: 320 ident: bib47 article-title: Selective organ targeting (SORT) nanoparticles for tissue-specific mRNA delivery and CRISPR–Cas gene editing publication-title: Nat Nanotechnol – volume: 97 start-page: 726 year: 2008 end-page: 745 ident: bib88 article-title: Nonviral approaches for targeted delivery of plasmid DNA and oligonucleotide publication-title: J Pharmacol Sci – volume: 100 start-page: 5789 year: 2003 end-page: 5794 ident: bib122 article-title: Polo-like kinase (Plk)1 depletion induces apoptosis in cancer cells publication-title: Proc Natl Acad Sci USA – volume: 11 year: 2019 ident: bib140 article-title: Durable anticancer immunity from intratumoral administration of IL-23, IL-36γ, and OX40L mRNAs publication-title: Sci Transl Med – volume: 6 year: 2020 ident: bib121 article-title: CRISPR-Cas9 genome editing using targeted lipid nanoparticles for cancer therapy publication-title: Sci Adv – volume: 11 start-page: 5339 year: 2020 ident: bib141 article-title: Dual mRNA therapy restores metabolic function in long-term studies in mice with propionic acidemia publication-title: Nat Commun – volume: 59 start-page: 357 year: 2003 end-page: 366 ident: bib55 article-title: Positron emission tomography microdosing: a new concept with application in tracer and early clinical drug development publication-title: Eur J Clin Pharmacol – volume: 118 year: 2021 ident: bib118 article-title: Lipid nanoparticle-mediated codelivery of Cas9 mRNA and single-guide RNA achieves liver-specific in vivo genome editing of Angptl3 publication-title: Proc Natl Acad Sci USA – volume: 1 start-page: e37 year: 2012 ident: bib27 article-title: Microfluidic synthesis of highly potent limit-size lipid nanoparticles for in vivo delivery of siRNA publication-title: Mol Ther Nucleic Acids – volume: 102 start-page: 8369 year: 2005 end-page: 8374 ident: bib74 article-title: Use of DNA barcodes to identify flowering plants publication-title: Proc Natl Acad Sci USA – volume: 40 start-page: 89 year: 1999 end-page: 102 ident: bib93 article-title: Possibility of active targeting to tumor tissues with liposomes publication-title: Adv Drug Deliv Rev – volume: 42 start-page: 448 year: 2021 end-page: 460 ident: bib13 article-title: The importance of apparent pKa in the development of nanoparticles encapsulating siRNA and mRNA publication-title: Trends Pharmacol Sci – volume: 63 start-page: 152 year: 2011 end-page: 160 ident: bib21 article-title: A multifunctional envelope type nano device (MEND) for gene delivery to tumours based on the EPR effect: a strategy for overcoming the PEG dilemma publication-title: Adv Drug Deliv Rev – volume: 22 start-page: 2227 year: 2018 end-page: 2235 ident: bib116 article-title: A single administration of CRISPR/Cas9 lipid nanoparticles achieves robust and persistent in vivo genome editing publication-title: Cell Rep – volume: 33 start-page: 4166 year: 2012 end-page: 4186 ident: bib89 article-title: A review of glycosylated carriers for drug delivery publication-title: Biomaterials – volume: 25 start-page: 229 year: 2019 end-page: 233 ident: bib105 article-title: Development of a gene-editing approach to restore vision loss in Leber congenital amaurosis type 10 publication-title: Nat Med – volume: 28 start-page: 172 year: 2010 end-page: 176 ident: bib11 article-title: Rational design of cationic lipids for siRNA delivery publication-title: Nat Biotechnol – volume: 33 year: 2021 ident: bib139 article-title: mRNA delivery of a bispecific single-domain antibody to polarize tumor-associated macrophages and synergize immunotherapy against liver malignancies publication-title: Adv Mater – volume: 15 start-page: 7300 year: 2015 end-page: 7306 ident: bib20 article-title: Optimization of lipid nanoparticle formulations for mRNA delivery in vivo with fractional factorial and definitive screening designs publication-title: Nano Lett – volume: 4 year: 2019 ident: bib137 article-title: A lipid-encapsulated mRNA encoding a potently neutralizing human monoclonal antibody protects against chikungunya infection publication-title: Sci Immunol – volume: 361 start-page: 866 year: 2018 end-page: 869 ident: bib106 article-title: CRISPR-Cas guides the future of genetic engineering publication-title: Science – volume: 154–155 start-page: 37 year: 2020 end-page: 63 ident: bib4 article-title: Lipid nanoparticles for nucleic acid delivery: current perspectives publication-title: Adv Drug Deliv Rev – volume: 19 start-page: 191 year: 2002 end-page: 233 ident: bib41 article-title: Factors affecting drug and gene delivery: effects of interaction with blood components publication-title: Crit Rev Ther Drug Carrier Syst – volume: 32 year: 2020 ident: bib143 article-title: Mild innate immune activation overrides efficient nanoparticle-mediated RNA delivery publication-title: Adv Mater – volume: 83 start-page: 8604 year: 2011 end-page: 8610 ident: bib75 article-title: High-throughput droplet digital PCR system for absolute quantitation of DNA copy number publication-title: Anal Chem – volume: 14 start-page: 1084 year: 2019 end-page: 1087 ident: bib25 article-title: The Onpattro story and the clinical translation of nanomedicines containing nucleic acid-based drugs publication-title: Nat Nanotechnol – volume: 16 start-page: 387 year: 2017 end-page: 399 ident: bib110 article-title: Delivery technologies for genome editing publication-title: Nat Rev Drug Discov – volume: 38 start-page: 892 year: 2020 end-page: 900 ident: bib128 article-title: Directed evolution of adenine base editors with increased activity and therapeutic application publication-title: Nat Biotechnol – volume: 16 start-page: 1030 year: 2021 end-page: 1038 ident: bib79 article-title: Conformation-sensitive targeting of lipid nanoparticles for RNA therapeutics publication-title: Nat Nanotechnol – volume: 114 start-page: 2060 year: 2017 end-page: 2065 ident: bib67 article-title: Barcoded nanoparticles for high throughput in vivo discovery of targeted therapeutics publication-title: Proc Natl Acad Sci USA – volume: 38 start-page: 44 year: 2020 end-page: 49 ident: bib126 article-title: Polymer-stabilized Cas9 nanoparticles and modified repair templates increase genome editing efficiency publication-title: Nat Biotechnol – volume: 32 year: 2020 ident: bib80 article-title: A combinatorial library of lipid nanoparticles for RNA delivery to leukocytes publication-title: Adv Mater – volume: 19 start-page: 249 year: 2011 end-page: 255 ident: bib63 article-title: Stoichiometry-focused publication-title: Bioorg Med Chem – volume: 148 start-page: 33 year: 2012 end-page: 45 ident: bib51 article-title: Lineage tracing publication-title: Cell – volume: 9 start-page: 6706 year: 2015 end-page: 6716 ident: bib81 article-title: Systemic gene silencing in primary T lymphocytes using targeted lipid nanoparticles publication-title: ACS Nano – volume: 107 start-page: 1864 year: 2010 end-page: 1869 ident: bib18 article-title: Lipid-like materials for low-dose, in vivo gene silencing publication-title: Proc Natl Acad Sci USA – volume: 16 start-page: 1065 year: 2019 end-page: 1073 ident: bib60 article-title: Improved immuno-PET imaging of HER2-positive tumors in mice: urokinase injection-triggered clearance enhancement of 64Cu-trastuzumab publication-title: Mol Pharm – volume: 356 start-page: 438 year: 2017 end-page: 442 ident: bib132 article-title: Nucleic acid detection with CRISPR-Cas13a/C2c2 publication-title: Science – volume: 18 start-page: 7590 year: 2018 end-page: 7600 ident: bib72 article-title: Modifying a commonly expressed endocytic receptor retargets nanoparticles in vivo publication-title: Nano Lett – volume: 5 start-page: 496 year: 2008 end-page: 504 ident: bib82 article-title: Pharmacokinetics and biodistribution of nanoparticles publication-title: Mol Pharm – volume: 353 start-page: aaf5573 year: 2016 ident: bib133 article-title: C2c2 is a single-component programmable RNA-guided RNA-targeting CRISPR effector publication-title: Science – volume: 31 start-page: 2046 year: 2020 end-page: 2059 ident: bib46 article-title: The biomolecular corona of lipid nanoparticles for gene therapy publication-title: Bioconjugate Chem – volume: 39 start-page: 717 year: 2021 end-page: 726 ident: bib135 article-title: Treatment of influenza and SARS-CoV-2 infections via mRNA-encoded Cas13a in rodents publication-title: Nat Biotechnol – volume: 52 start-page: 950 year: 2011 end-page: 957 ident: bib57 article-title: Developmental changes in P-glycoprotein function in the blood-brain barrier of nonhuman primates: PET study with R- publication-title: J Nucl Med – volume: 5 start-page: 1546 year: 2019 end-page: 1558 ident: bib76 article-title: Mannosylation of LNP results in improved potency for self-amplifying RNA (SAM) vaccines publication-title: ACS Infect Dis – volume: 9 start-page: 4493 year: 2018 ident: bib78 article-title: Cell specific delivery of modified mRNA expressing therapeutic proteins to leukocytes publication-title: Nat Commun – volume: 346 year: 2014 ident: bib100 article-title: Genome editing. The new frontier of genome engineering with CRISPR-Cas9 publication-title: Science – volume: 11 start-page: 3232 year: 2020 ident: bib120 article-title: Systemic nanoparticle delivery of CRISPR-Cas9 ribonucleoproteins for effective tissue specific genome editing publication-title: Nat Commun – volume: 114 start-page: E1941 year: 2017 end-page: E1950 ident: bib26 article-title: Systemic delivery of factor IX messenger RNA for protein replacement therapy publication-title: Proc Natl Acad Sci USA – volume: 63 start-page: 494 year: 2011 end-page: 502 ident: bib54 article-title: Impact of microdosing clinical study - why necessary and how useful? publication-title: Adv Drug Deliv Rev – volume: 339 start-page: 819 year: 2013 end-page: 823 ident: bib101 article-title: Multiplex genome engineering using CRISPR/Cas systems publication-title: Science – volume: 8 start-page: 14630 year: 2017 ident: bib136 article-title: Administration of nucleoside-modified mRNA encoding broadly neutralizing antibody protects humanized mice from HIV-1 challenge publication-title: Nat Commun – volume: 52 start-page: 2435 year: 2019 end-page: 2444 ident: bib3 article-title: Lipid nanoparticle technology for clinical translation of siRNA therapeutics publication-title: Acc Chem Res – volume: 18 start-page: 1357 year: 2010 end-page: 1364 ident: bib38 article-title: Targeted delivery of RNAi therapeutics with endogenous and exogenous ligand-based mechanisms publication-title: Mol Ther – volume: 7 start-page: 11856 year: 2016 ident: bib36 article-title: A luciferin analogue generating near-infrared bioluminescence achieves highly sensitive deep-tissue imaging publication-title: Nat Commun – volume: 533 start-page: 420 year: 2016 end-page: 424 ident: bib108 article-title: Programmable editing of a target base in genomic DNA without double-stranded DNA cleavage publication-title: Nature – volume: 15 start-page: 1 year: 2019 end-page: 11 ident: bib15 article-title: Optimization of lipid nanoparticles for intramuscular administration of mRNA vaccines publication-title: Mol Ther Nucleic Acids – volume: 19 start-page: 770 year: 2018 end-page: 788 ident: bib107 article-title: Base editing: precision chemistry on the genome and transcriptome of living cells publication-title: Nat Rev Genet – volume: 6 year: 2020 ident: bib144 article-title: Increased PIP3 activity blocks nanoparticle mRNA delivery publication-title: Sci Adv – volume: 359 start-page: 935 year: 2018 end-page: 939 ident: bib37 article-title: Single-cell bioluminescence imaging of deep tissue in freely moving animals publication-title: Science – volume: 101 start-page: 9193 year: 2004 end-page: 9198 ident: bib95 article-title: Anchored periplasmic expression, a versatile technology for the isolation of high-affinity antibodies from Escherichia coli-expressed libraries publication-title: Proc Natl Acad Sci USA – volume: 5 start-page: 101 year: 2020 ident: bib5 article-title: Therapeutic siRNA: state of the art publication-title: Signal Transduct Target Ther – volume: 159 start-page: 344 year: 2020 end-page: 363 ident: bib8 article-title: Lipid nanoparticle technology for therapeutic gene regulation in the liver publication-title: Adv Drug Deliv Rev – volume: 154–155 start-page: 210 year: 2020 end-page: 226 ident: bib17 article-title: Development of lipid-like materials for RNA delivery based on intracellular environment-responsive membrane destabilization and spontaneous collapse publication-title: Adv Drug Deliv Rev – volume: 17 start-page: 306 year: 2000 end-page: 313 ident: bib86 article-title: In vivo gene delivery to the liver using novel galactosylated cationic liposomes publication-title: Pharm Res (N Y) – volume: 120 start-page: 3787 year: 2020 end-page: 3851 ident: bib58 article-title: ImmunoPET: concept, design, and applications publication-title: Chem Rev – volume: 53 start-page: 423 year: 1988 end-page: 432 ident: bib94 article-title: A single amino acid determinant of the membrane localization of lipoproteins in E. coli publication-title: Cell – volume: 11 start-page: 7572 issue: 8 year: 2017 ident: 10.1016/j.dmpk.2022.100450_bib12 article-title: Next-generation lipids in RNA interference therapeutics publication-title: ACS Nano doi: 10.1021/acsnano.7b04734 – volume: 9 start-page: 6706 issue: 7 year: 2015 ident: 10.1016/j.dmpk.2022.100450_bib81 article-title: Systemic gene silencing in primary T lymphocytes using targeted lipid nanoparticles publication-title: ACS Nano doi: 10.1021/acsnano.5b02796 – volume: 28 start-page: 172 issue: 2 year: 2010 ident: 10.1016/j.dmpk.2022.100450_bib11 article-title: Rational design of cationic lipids for siRNA delivery publication-title: Nat Biotechnol doi: 10.1038/nbt.1602 – volume: 15 start-page: 1 year: 2019 ident: 10.1016/j.dmpk.2022.100450_bib15 article-title: Optimization of lipid nanoparticles for intramuscular administration of mRNA vaccines publication-title: Mol Ther Nucleic Acids doi: 10.1016/j.omtn.2019.01.013 – volume: 17 start-page: 545 issue: 5 year: 2003 ident: 10.1016/j.dmpk.2022.100450_bib33 article-title: Molecular imaging in living subjects: seeing fundamental biological processes in a new light publication-title: Genes Dev doi: 10.1101/gad.1047403 – volume: 8 start-page: 14630 year: 2017 ident: 10.1016/j.dmpk.2022.100450_bib136 article-title: Administration of nucleoside-modified mRNA encoding broadly neutralizing antibody protects humanized mice from HIV-1 challenge publication-title: Nat Commun doi: 10.1038/ncomms14630 – volume: 38 start-page: 2094 issue: 16 year: 2002 ident: 10.1016/j.dmpk.2022.100450_bib53 article-title: PET for in vivo pharmacokinetic and pharmacodynamic measurements publication-title: Eur J Cancer doi: 10.1016/S0959-8049(02)00413-6 – volume: 356 start-page: 438 issue: 6336 year: 2017 ident: 10.1016/j.dmpk.2022.100450_bib132 article-title: Nucleic acid detection with CRISPR-Cas13a/C2c2 publication-title: Science doi: 10.1126/science.aam9321 – volume: 33 issue: 30 year: 2021 ident: 10.1016/j.dmpk.2022.100450_bib125 article-title: All-in-one dendrimer-based lipid nanoparticles enable precise HDR-mediated gene editing in vivo publication-title: Adv Mater doi: 10.1002/adma.202006619 – volume: 7 issue: 3 year: 2021 ident: 10.1016/j.dmpk.2022.100450_bib142 article-title: Ionizable lipid nanoparticles for in utero mRNA delivery publication-title: Sci Adv doi: 10.1126/sciadv.aba1028 – volume: 42 start-page: 448 issue: 6 year: 2021 ident: 10.1016/j.dmpk.2022.100450_bib13 article-title: The importance of apparent pKa in the development of nanoparticles encapsulating siRNA and mRNA publication-title: Trends Pharmacol Sci doi: 10.1016/j.tips.2021.03.002 – volume: 32 issue: 12 year: 2020 ident: 10.1016/j.dmpk.2022.100450_bib80 article-title: A combinatorial library of lipid nanoparticles for RNA delivery to leukocytes publication-title: Adv Mater – volume: 114 start-page: 2060 issue: 8 year: 2017 ident: 10.1016/j.dmpk.2022.100450_bib67 article-title: Barcoded nanoparticles for high throughput in vivo discovery of targeted therapeutics publication-title: Proc Natl Acad Sci USA doi: 10.1073/pnas.1620874114 – volume: 27 start-page: 710 issue: 4 year: 2019 ident: 10.1016/j.dmpk.2022.100450_bib9 article-title: Delivering the messenger: advances in technologies for therapeutic mRNA delivery publication-title: Mol Ther doi: 10.1016/j.ymthe.2019.02.012 – volume: 217 start-page: 345 year: 2015 ident: 10.1016/j.dmpk.2022.100450_bib34 article-title: Expression kinetics of nucleoside-modified mRNA delivered in lipid nanoparticles to mice by various routes publication-title: J Contr Release doi: 10.1016/j.jconrel.2015.08.007 – volume: 4 issue: 35 year: 2019 ident: 10.1016/j.dmpk.2022.100450_bib137 article-title: A lipid-encapsulated mRNA encoding a potently neutralizing human monoclonal antibody protects against chikungunya infection publication-title: Sci Immunol doi: 10.1126/sciimmunol.aaw6647 – volume: 128 start-page: 84 year: 2018 ident: 10.1016/j.dmpk.2022.100450_bib29 article-title: Advances in microfluidics for lipid nanoparticles and extracellular vesicles and applications in drug delivery systems publication-title: Adv Drug Deliv Rev doi: 10.1016/j.addr.2018.03.008 – volume: 5 start-page: 101 issue: 1 year: 2020 ident: 10.1016/j.dmpk.2022.100450_bib5 article-title: Therapeutic siRNA: state of the art publication-title: Signal Transduct Target Ther doi: 10.1038/s41392-020-0207-x – volume: 27 start-page: 1415 issue: 8 year: 2019 ident: 10.1016/j.dmpk.2022.100450_bib138 article-title: mRNA delivery for therapeutic anti-HER2 antibody expression in vivo publication-title: Mol Ther doi: 10.1016/j.ymthe.2019.05.012 – volume: 6 issue: 30 year: 2020 ident: 10.1016/j.dmpk.2022.100450_bib144 article-title: Increased PIP3 activity blocks nanoparticle mRNA delivery publication-title: Sci Adv doi: 10.1126/sciadv.aba5672 – volume: 39 start-page: 949 issue: 8 year: 2021 ident: 10.1016/j.dmpk.2022.100450_bib129 article-title: In vivo adenine base editing of PCSK9 in macaques reduces LDL cholesterol levels publication-title: Nat Biotechnol doi: 10.1038/s41587-021-00933-4 – volume: 15 start-page: 646 issue: 8 year: 2020 ident: 10.1016/j.dmpk.2022.100450_bib6 article-title: COVID-19 vaccine development and a potential nanomaterial path forward publication-title: Nat Nanotechnol doi: 10.1038/s41565-020-0737-y – volume: 31 issue: 14 year: 2019 ident: 10.1016/j.dmpk.2022.100450_bib71 article-title: Nanoparticles containing oxidized cholesterol deliver mRNA to the liver microenvironment at clinically relevant doses publication-title: Adv Mater – volume: 83 start-page: 8604 issue: 22 year: 2011 ident: 10.1016/j.dmpk.2022.100450_bib75 article-title: High-throughput droplet digital PCR system for absolute quantitation of DNA copy number publication-title: Anal Chem doi: 10.1021/ac202028g – volume: 15 start-page: 313 issue: 4 year: 2020 ident: 10.1016/j.dmpk.2022.100450_bib47 article-title: Selective organ targeting (SORT) nanoparticles for tissue-specific mRNA delivery and CRISPR–Cas gene editing publication-title: Nat Nanotechnol doi: 10.1038/s41565-020-0669-6 – volume: 1 start-page: e37 issue: 8 year: 2012 ident: 10.1016/j.dmpk.2022.100450_bib27 article-title: Microfluidic synthesis of highly potent limit-size lipid nanoparticles for in vivo delivery of siRNA publication-title: Mol Ther Nucleic Acids doi: 10.1038/mtna.2012.28 – volume: 7 issue: 9 year: 2021 ident: 10.1016/j.dmpk.2022.100450_bib49 article-title: Engineered ionizable lipid nanoparticles for targeted delivery of RNA therapeutics into different types of cells in the liver publication-title: Sci Adv doi: 10.1126/sciadv.abf4398 – volume: 52 start-page: 2435 issue: 9 year: 2019 ident: 10.1016/j.dmpk.2022.100450_bib3 article-title: Lipid nanoparticle technology for clinical translation of siRNA therapeutics publication-title: Acc Chem Res doi: 10.1021/acs.accounts.9b00368 – volume: 120 start-page: 3787 issue: 8 year: 2020 ident: 10.1016/j.dmpk.2022.100450_bib58 article-title: ImmunoPET: concept, design, and applications publication-title: Chem Rev doi: 10.1021/acs.chemrev.9b00738 – volume: 2 start-page: 1120 issue: 8 year: 2013 ident: 10.1016/j.dmpk.2022.100450_bib16 article-title: A neutral envelope-type nanoparticle containing pH-responsive and ss-cleavable lipid-like material as a carrier for plasmid DNA publication-title: Adv Healthc Mater doi: 10.1002/adhm.201200431 – volume: 168 start-page: 3 year: 2021 ident: 10.1016/j.dmpk.2022.100450_bib115 article-title: Rational designs of in vivo CRISPR-Cas delivery systems publication-title: Adv Drug Deliv Rev doi: 10.1016/j.addr.2019.11.005 – volume: 32 issue: 1 year: 2020 ident: 10.1016/j.dmpk.2022.100450_bib143 article-title: Mild innate immune activation overrides efficient nanoparticle-mediated RNA delivery publication-title: Adv Mater doi: 10.1002/adma.201904905 – volume: 316 start-page: 404 year: 2019 ident: 10.1016/j.dmpk.2022.100450_bib70 article-title: Ionizable lipid nanoparticles encapsulating barcoded mRNA for accelerated in vivo delivery screening publication-title: J Contr Release doi: 10.1016/j.jconrel.2019.10.028 – volume: 359 start-page: 935 issue: 6378 year: 2018 ident: 10.1016/j.dmpk.2022.100450_bib37 article-title: Single-cell bioluminescence imaging of deep tissue in freely moving animals publication-title: Science doi: 10.1126/science.aaq1067 – volume: 24 start-page: 1519 issue: 10 year: 2018 ident: 10.1016/j.dmpk.2022.100450_bib131 article-title: Treatment of a metabolic liver disease by in vivo genome base editing in adult mice publication-title: Nat Med doi: 10.1038/s41591-018-0209-1 – volume: 346 issue: 6213 year: 2014 ident: 10.1016/j.dmpk.2022.100450_bib100 article-title: Genome editing. The new frontier of genome engineering with CRISPR-Cas9 publication-title: Science doi: 10.1126/science.1258096 – start-page: 1 year: 2021 ident: 10.1016/j.dmpk.2022.100450_bib2 article-title: Lipid nanoparticles for mRNA delivery publication-title: Nat Rev Mater – volume: 38 start-page: 845 issue: 7 year: 2020 ident: 10.1016/j.dmpk.2022.100450_bib111 article-title: The delivery challenge: fulfilling the promise of therapeutic genome editing publication-title: Nat Biotechnol doi: 10.1038/s41587-020-0565-5 – volume: 189 start-page: 1961 issue: 12 year: 1999 ident: 10.1016/j.dmpk.2022.100450_bib90 article-title: Mannose receptor and its putative ligands in normal murine lymphoid and nonlymphoid organs: in situ expression of mannose receptor by selected macrophages, endothelial cells, perivascular microglia, and mesangial cells, but not dendritic cells publication-title: J Exp Med doi: 10.1084/jem.189.12.1961 – volume: 5 start-page: 1546 issue: 9 year: 2019 ident: 10.1016/j.dmpk.2022.100450_bib76 article-title: Mannosylation of LNP results in improved potency for self-amplifying RNA (SAM) vaccines publication-title: ACS Infect Dis doi: 10.1021/acsinfecdis.9b00084 – volume: 29 start-page: 1005 issue: 11 year: 2011 ident: 10.1016/j.dmpk.2022.100450_bib19 article-title: Therapeutic siRNA silencing in inflammatory monocytes in mice publication-title: Nat Biotechnol doi: 10.1038/nbt.1989 – volume: 180 start-page: 92 year: 2014 ident: 10.1016/j.dmpk.2022.100450_bib64 article-title: Quantitative evaluation of the improvement in the pharmacokinetics of a nucleic acid drug delivery system by dynamic PET imaging with 18F-incorporated oligodeoxynucleotides publication-title: J Contr Release doi: 10.1016/j.jconrel.2014.02.014 – volume: 16 start-page: 1030 issue: 9 year: 2021 ident: 10.1016/j.dmpk.2022.100450_bib79 article-title: Conformation-sensitive targeting of lipid nanoparticles for RNA therapeutics publication-title: Nat Nanotechnol doi: 10.1038/s41565-021-00928-x – volume: 154–155 start-page: 210 year: 2020 ident: 10.1016/j.dmpk.2022.100450_bib17 article-title: Development of lipid-like materials for RNA delivery based on intracellular environment-responsive membrane destabilization and spontaneous collapse publication-title: Adv Drug Deliv Rev doi: 10.1016/j.addr.2020.07.001 – volume: 114 start-page: E1941 issue: 10 year: 2017 ident: 10.1016/j.dmpk.2022.100450_bib26 article-title: Systemic delivery of factor IX messenger RNA for protein replacement therapy publication-title: Proc Natl Acad Sci USA doi: 10.1073/pnas.1619653114 – volume: 353 start-page: aaf5573 issue: 6299 year: 2016 ident: 10.1016/j.dmpk.2022.100450_bib133 article-title: C2c2 is a single-component programmable RNA-guided RNA-targeting CRISPR effector publication-title: Science doi: 10.1126/science.aaf5573 – volume: 159 start-page: 344 year: 2020 ident: 10.1016/j.dmpk.2022.100450_bib8 article-title: Lipid nanoparticle technology for therapeutic gene regulation in the liver publication-title: Adv Drug Deliv Rev doi: 10.1016/j.addr.2020.06.026 – volume: 97 start-page: 726 issue: 2 year: 2008 ident: 10.1016/j.dmpk.2022.100450_bib88 article-title: Nonviral approaches for targeted delivery of plasmid DNA and oligonucleotide publication-title: J Pharmacol Sci doi: 10.1002/jps.21024 – volume: 100 start-page: 5789 issue: 10 year: 2003 ident: 10.1016/j.dmpk.2022.100450_bib122 article-title: Polo-like kinase (Plk)1 depletion induces apoptosis in cancer cells publication-title: Proc Natl Acad Sci USA doi: 10.1073/pnas.1031523100 – volume: 83 start-page: 727 year: 2014 ident: 10.1016/j.dmpk.2022.100450_bib98 article-title: Selection-based discovery of druglike macrocyclic peptides publication-title: Annu Rev Biochem doi: 10.1146/annurev-biochem-060713-035456 – volume: 122 start-page: 2073 issue: 7 year: 2018 ident: 10.1016/j.dmpk.2022.100450_bib31 article-title: Structure of lipid nanoparticles containing siRNA or mRNA by dynamic nuclear polarization-enhanced NMR spectroscopy publication-title: J Phys Chem B doi: 10.1021/acs.jpcb.7b10795 – volume: 18 start-page: 7590 issue: 12 year: 2018 ident: 10.1016/j.dmpk.2022.100450_bib72 article-title: Modifying a commonly expressed endocytic receptor retargets nanoparticles in vivo publication-title: Nano Lett doi: 10.1021/acs.nanolett.8b03149 – volume: 9 start-page: 994 issue: 12 year: 2016 ident: 10.1016/j.dmpk.2022.100450_bib97 article-title: Fc-binding ligands of immunoglobulin G: an overview of high affinity proteins and peptides publication-title: Materials doi: 10.3390/ma9120994 – volume: 19 start-page: 770 issue: 12 year: 2018 ident: 10.1016/j.dmpk.2022.100450_bib107 article-title: Base editing: precision chemistry on the genome and transcriptome of living cells publication-title: Nat Rev Genet doi: 10.1038/s41576-018-0059-1 – volume: 38 start-page: 892 issue: 7 year: 2020 ident: 10.1016/j.dmpk.2022.100450_bib128 article-title: Directed evolution of adenine base editors with increased activity and therapeutic application publication-title: Nat Biotechnol doi: 10.1038/s41587-020-0491-6 – volume: 74 start-page: 185 issue: 1 year: 1993 ident: 10.1016/j.dmpk.2022.100450_bib96 article-title: α4β7 integrin mediates lymphocyte binding to the mucosal vascular addressin MAdCAM-1 publication-title: Cell doi: 10.1016/0092-8674(93)90305-A – volume: 15 start-page: 7300 issue: 11 year: 2015 ident: 10.1016/j.dmpk.2022.100450_bib20 article-title: Optimization of lipid nanoparticle formulations for mRNA delivery in vivo with fractional factorial and definitive screening designs publication-title: Nano Lett doi: 10.1021/acs.nanolett.5b02497 – volume: 19 start-page: 249 issue: 1 year: 2011 ident: 10.1016/j.dmpk.2022.100450_bib63 article-title: Stoichiometry-focused 18F-labeling of alkyne-substituted oligodeoxynucleotides using azido([18F]fluoromethyl)benzenes by Cu-catalyzed Huisgen reaction publication-title: Bioorg Med Chem doi: 10.1016/j.bmc.2010.11.033 – volume: 16 start-page: 387 issue: 6 year: 2017 ident: 10.1016/j.dmpk.2022.100450_bib110 article-title: Delivery technologies for genome editing publication-title: Nat Rev Drug Discov doi: 10.1038/nrd.2016.280 – volume: 9 start-page: 1449 issue: 4 year: 2021 ident: 10.1016/j.dmpk.2022.100450_bib69 article-title: Helper lipid structure influences protein adsorption and delivery of lipid nanoparticles to spleen and liver publication-title: Biomater Sci doi: 10.1039/D0BM01609H – volume: 87 start-page: 5744 issue: 15 year: 1990 ident: 10.1016/j.dmpk.2022.100450_bib92 article-title: Lipid composition is important for highly efficient target binding and retention of immunoliposomes publication-title: Proc Natl Acad Sci USA doi: 10.1073/pnas.87.15.5744 – volume: 29 issue: 14 year: 2017 ident: 10.1016/j.dmpk.2022.100450_bib23 article-title: Rational design of cancer nanomedicine: nanoproperty integration and synchronization publication-title: Adv Mater doi: 10.1002/adma.201606628 – volume: 154–155 start-page: 37 year: 2020 ident: 10.1016/j.dmpk.2022.100450_bib4 article-title: Lipid nanoparticles for nucleic acid delivery: current perspectives publication-title: Adv Drug Deliv Rev doi: 10.1016/j.addr.2020.06.002 – volume: 92 start-page: 156 year: 2021 ident: 10.1016/j.dmpk.2022.100450_bib61 article-title: Review: PET imaging with macro- and middle-sized molecular probes publication-title: Nucl Med Biol doi: 10.1016/j.nucmedbio.2020.06.007 – volume: 184 start-page: 1589 issue: 6 year: 2021 ident: 10.1016/j.dmpk.2022.100450_bib7 article-title: Novel approaches for vaccine development publication-title: Cell doi: 10.1016/j.cell.2021.02.030 – volume: 7 start-page: 292 issue: 4 year: 2000 ident: 10.1016/j.dmpk.2022.100450_bib85 article-title: Mannose receptor-mediated gene transfer into macrophages using novel mannosylated cationic liposomes publication-title: Gene Ther doi: 10.1038/sj.gt.3301089 – volume: 28 start-page: 3633 issue: 7 year: 2012 ident: 10.1016/j.dmpk.2022.100450_bib28 article-title: Bottom-up design and synthesis of limit size lipid nanoparticle systems with aqueous and triglyceride cores using millisecond microfluidic mixing publication-title: Langmuir doi: 10.1021/la204833h – volume: 24 start-page: 260 issue: 2 year: 2005 ident: 10.1016/j.dmpk.2022.100450_bib123 article-title: Differential regulation of polo-like kinase 1, 2, 3, and 4 gene expression in mammalian cells and tissues publication-title: Oncogene doi: 10.1038/sj.onc.1208219 – volume: 53 start-page: 423 issue: 3 year: 1988 ident: 10.1016/j.dmpk.2022.100450_bib94 article-title: A single amino acid determinant of the membrane localization of lipoproteins in E. coli publication-title: Cell doi: 10.1016/0092-8674(88)90162-6 – volume: 31 start-page: 397 issue: 7 year: 2013 ident: 10.1016/j.dmpk.2022.100450_bib103 article-title: ZFN, TALEN, and CRISPR/Cas-based methods for genome engineering publication-title: Trends Biotechnol doi: 10.1016/j.tibtech.2013.04.004 – volume: 25 start-page: 229 issue: 2 year: 2019 ident: 10.1016/j.dmpk.2022.100450_bib105 article-title: Development of a gene-editing approach to restore vision loss in Leber congenital amaurosis type 10 publication-title: Nat Med doi: 10.1038/s41591-018-0327-9 – volume: 39 start-page: 717 issue: 6 year: 2021 ident: 10.1016/j.dmpk.2022.100450_bib135 article-title: Treatment of influenza and SARS-CoV-2 infections via mRNA-encoded Cas13a in rodents publication-title: Nat Biotechnol doi: 10.1038/s41587-021-00822-w – volume: 101 start-page: 9193 issue: 25 year: 2004 ident: 10.1016/j.dmpk.2022.100450_bib95 article-title: Anchored periplasmic expression, a versatile technology for the isolation of high-affinity antibodies from Escherichia coli-expressed libraries publication-title: Proc Natl Acad Sci USA doi: 10.1073/pnas.0400187101 – volume: 116 start-page: 18440 issue: 34 year: 2012 ident: 10.1016/j.dmpk.2022.100450_bib32 article-title: Lipid nanoparticles containing siRNA synthesized by microfluidic mixing exhibit an electron-dense nanostructured core publication-title: J Phys Chem C Nanomater Interfaces doi: 10.1021/jp303267y – volume: 7 start-page: 11856 year: 2016 ident: 10.1016/j.dmpk.2022.100450_bib36 article-title: A luciferin analogue generating near-infrared bioluminescence achieves highly sensitive deep-tissue imaging publication-title: Nat Commun doi: 10.1038/ncomms11856 – volume: 601 start-page: 120586 year: 2021 ident: 10.1016/j.dmpk.2022.100450_bib10 article-title: mRNA-lipid nanoparticle COVID-19 vaccines: structure and stability publication-title: Int J Pharm doi: 10.1016/j.ijpharm.2021.120586 – volume: 258 year: 2020 ident: 10.1016/j.dmpk.2022.100450_bib114 article-title: Overcoming the delivery problem for therapeutic genome editing: current status and perspective of non-viral methods publication-title: Biomaterials doi: 10.1016/j.biomaterials.2020.120282 – volume: 19 start-page: 388 issue: 4 year: 2014 ident: 10.1016/j.dmpk.2022.100450_bib99 article-title: mRNA display: from basic principles to macrocycle drug discovery publication-title: Drug Discov Today doi: 10.1016/j.drudis.2013.10.011 – volume: 25 start-page: 1234 issue: 1 year: 2018 ident: 10.1016/j.dmpk.2022.100450_bib112 article-title: Delivering crispr: a review of the challenges and approaches publication-title: Drug Deliv doi: 10.1080/10717544.2018.1474964 – volume: 3 start-page: 371 issue: 5 year: 2019 ident: 10.1016/j.dmpk.2022.100450_bib66 article-title: Visualization of early events in mRNA vaccine delivery in non-human primates via PET–CT and near-infrared imaging publication-title: Nat Biomed Eng doi: 10.1038/s41551-019-0378-3 – volume: 109 start-page: 6241 issue: 16 year: 2012 ident: 10.1016/j.dmpk.2022.100450_bib73 article-title: Nuclear ribosomal internal transcribed spacer (ITS) region as a universal DNA barcode marker for Fungi publication-title: Proc Natl Acad Sci USA doi: 10.1073/pnas.1117018109 – volume: 11 start-page: 5339 issue: 1 year: 2020 ident: 10.1016/j.dmpk.2022.100450_bib141 article-title: Dual mRNA therapy restores metabolic function in long-term studies in mice with propionic acidemia publication-title: Nat Commun doi: 10.1038/s41467-020-19156-3 – volume: 17 start-page: 306 issue: 3 year: 2000 ident: 10.1016/j.dmpk.2022.100450_bib86 article-title: In vivo gene delivery to the liver using novel galactosylated cationic liposomes publication-title: Pharm Res (N Y) doi: 10.1023/A:1007501122611 – volume: 53 start-page: 871 issue: 8 year: 2005 ident: 10.1016/j.dmpk.2022.100450_bib84 article-title: Lipid carrier systems for targeted drug and gene delivery publication-title: Chem Pharm Bull doi: 10.1248/cpb.53.871 – volume: 33 start-page: 4166 issue: 16 year: 2012 ident: 10.1016/j.dmpk.2022.100450_bib89 article-title: A review of glycosylated carriers for drug delivery publication-title: Biomaterials doi: 10.1016/j.biomaterials.2012.02.033 – volume: 34 start-page: 328 issue: 3 year: 2016 ident: 10.1016/j.dmpk.2022.100450_bib124 article-title: Therapeutic genome editing by combined viral and non-viral delivery of CRISPR system components in vivo publication-title: Nat Biotechnol doi: 10.1038/nbt.3471 – volume: 16 start-page: 1065 issue: 3 year: 2019 ident: 10.1016/j.dmpk.2022.100450_bib60 article-title: Improved immuno-PET imaging of HER2-positive tumors in mice: urokinase injection-triggered clearance enhancement of 64Cu-trastuzumab publication-title: Mol Pharm doi: 10.1021/acs.molpharmaceut.8b01052 – volume: 22 start-page: 2227 issue: 9 year: 2018 ident: 10.1016/j.dmpk.2022.100450_bib116 article-title: A single administration of CRISPR/Cas9 lipid nanoparticles achieves robust and persistent in vivo genome editing publication-title: Cell Rep doi: 10.1016/j.celrep.2018.02.014 – volume: 8 start-page: 1172 issue: 4 year: 2002 ident: 10.1016/j.dmpk.2022.100450_bib91 article-title: Anti-HER2 immunoliposomes: enhanced efficacy attributable to targeted delivery publication-title: Clin Cancer Res – volume: 31 start-page: 2046 issue: 9 year: 2020 ident: 10.1016/j.dmpk.2022.100450_bib46 article-title: The biomolecular corona of lipid nanoparticles for gene therapy publication-title: Bioconjugate Chem doi: 10.1021/acs.bioconjchem.0c00366 – volume: 322 start-page: 217 year: 2020 ident: 10.1016/j.dmpk.2022.100450_bib45 article-title: Different kinetics for the hepatic uptake of lipid nanoparticles between the apolipoprotein E/low density lipoprotein receptor and the N-acetyl-D-galactosamine/asialoglycoprotein receptor pathway publication-title: J Contr Release doi: 10.1016/j.jconrel.2020.03.006 – volume: 15 start-page: 598 issue: 6 year: 2019 ident: 10.1016/j.dmpk.2022.100450_bib59 article-title: Macrocyclic peptide-based inhibition and imaging of hepatocyte growth factor publication-title: Nat Chem Biol doi: 10.1038/s41589-019-0285-7 – volume: 593 start-page: 429 issue: 7859 year: 2021 ident: 10.1016/j.dmpk.2022.100450_bib127 article-title: In vivo CRISPR base editing of PCSK9 durably lowers cholesterol in primates publication-title: Nature doi: 10.1038/s41586-021-03534-y – volume: 550 start-page: 280 issue: 7675 year: 2017 ident: 10.1016/j.dmpk.2022.100450_bib134 article-title: RNA targeting with CRISPR-Cas13 publication-title: Nature doi: 10.1038/nature24049 – volume: 31 issue: 33 year: 2019 ident: 10.1016/j.dmpk.2022.100450_bib117 article-title: Fast and efficient CRISPR/Cas9 genome editing in vivo enabled by bioreducible lipid and messenger RNA nanoparticles publication-title: Adv Mater doi: 10.1002/adma.201902575 – volume: 266 start-page: 17 year: 2017 ident: 10.1016/j.dmpk.2022.100450_bib113 article-title: Delivery strategies of the CRISPR-Cas9 gene-editing system for therapeutic applications publication-title: J Contr Release doi: 10.1016/j.jconrel.2017.09.012 – volume: 2 start-page: e139 issue: 12 year: 2013 ident: 10.1016/j.dmpk.2022.100450_bib24 article-title: Influence of polyethylene glycol lipid desorption rates on pharmacokinetics and pharmacodynamics of siRNA lipid nanoparticles publication-title: Mol Ther Nucleic Acids doi: 10.1038/mtna.2013.66 – volume: 11 start-page: 18806 issue: 40 year: 2019 ident: 10.1016/j.dmpk.2022.100450_bib43 article-title: The role of apolipoprotein- and vitronectin-enriched protein corona on lipid nanoparticles for- and vivo targeted delivery and transfection of oligonucleotides in murine tumor models publication-title: Nanoscale doi: 10.1039/C9NR05788A – volume: 36 start-page: 183 year: 2013 ident: 10.1016/j.dmpk.2022.100450_bib52 article-title: Genetic approaches to neural circuits in the mouse publication-title: Annu Rev Neurosci doi: 10.1146/annurev-neuro-062012-170307 – volume: 13 start-page: 133 issue: 1 year: 2010 ident: 10.1016/j.dmpk.2022.100450_bib50 article-title: A robust and high-throughput Cre reporting and characterization system for the whole mouse brain publication-title: Nat Neurosci doi: 10.1038/nn.2467 – volume: 533 start-page: 420 issue: 7603 year: 2016 ident: 10.1016/j.dmpk.2022.100450_bib108 article-title: Programmable editing of a target base in genomic DNA without double-stranded DNA cleavage publication-title: Nature doi: 10.1038/nature17946 – volume: 52 start-page: 249 issue: 2 year: 2011 ident: 10.1016/j.dmpk.2022.100450_bib56 article-title: PET imaging of the gastrointestinal absorption of orally administered drugs in conscious and anesthetized rats publication-title: J Nucl Med doi: 10.2967/jnumed.110.081539 – volume: 52 start-page: 950 issue: 6 year: 2011 ident: 10.1016/j.dmpk.2022.100450_bib57 article-title: Developmental changes in P-glycoprotein function in the blood-brain barrier of nonhuman primates: PET study with R-11C-verapamil and 11C-oseltamivir publication-title: J Nucl Med doi: 10.2967/jnumed.110.083949 – volume: 6 issue: 47 year: 2020 ident: 10.1016/j.dmpk.2022.100450_bib121 article-title: CRISPR-Cas9 genome editing using targeted lipid nanoparticles for cancer therapy publication-title: Sci Adv doi: 10.1126/sciadv.abc9450 – volume: 25 start-page: 1467 issue: 7 year: 2017 ident: 10.1016/j.dmpk.2022.100450_bib1 article-title: Lipid nanoparticle systems for enabling gene therapies publication-title: Mol Ther doi: 10.1016/j.ymthe.2017.03.013 – volume: 9 start-page: 4493 issue: 1 year: 2018 ident: 10.1016/j.dmpk.2022.100450_bib78 article-title: Cell specific delivery of modified mRNA expressing therapeutic proteins to leukocytes publication-title: Nat Commun doi: 10.1038/s41467-018-06936-1 – volume: 190 start-page: 542 year: 2014 ident: 10.1016/j.dmpk.2022.100450_bib87 article-title: Glycosylation-mediated targeting of carriers publication-title: J Contr Release doi: 10.1016/j.jconrel.2014.06.001 – volume: 113 start-page: 2868 issue: 11 year: 2016 ident: 10.1016/j.dmpk.2022.100450_bib119 article-title: Efficient delivery of genome-editing proteins using bioreducible lipid nanoparticles publication-title: Proc Natl Acad Sci U S A doi: 10.1073/pnas.1520244113 – volume: 52 start-page: 165 issue: 2 year: 2001 ident: 10.1016/j.dmpk.2022.100450_bib40 article-title: Effects of erythrocytes and serum proteins on lung accumulation of lipoplexes containing cholesterol or DOPE as a helper lipid in the single-pass rat lung perfusion system publication-title: Eur J Pharm Biopharm doi: 10.1016/S0939-6411(01)00165-5 – volume: 18 start-page: 1357 issue: 7 year: 2010 ident: 10.1016/j.dmpk.2022.100450_bib38 article-title: Targeted delivery of RNAi therapeutics with endogenous and exogenous ligand-based mechanisms publication-title: Mol Ther doi: 10.1038/mt.2010.85 – volume: 240 start-page: 95 issue: 1–2 year: 2002 ident: 10.1016/j.dmpk.2022.100450_bib83 article-title: Liposome clearance in mice: the effect of a separate and combined presence of surface charge and polymer coating publication-title: Int J Pharm doi: 10.1016/S0378-5173(02)00129-1 – volume: 38 start-page: 44 issue: 1 year: 2020 ident: 10.1016/j.dmpk.2022.100450_bib126 article-title: Polymer-stabilized Cas9 nanoparticles and modified repair templates increase genome editing efficiency publication-title: Nat Biotechnol doi: 10.1038/s41587-019-0325-6 – volume: 14 start-page: 1084 issue: 12 year: 2019 ident: 10.1016/j.dmpk.2022.100450_bib25 article-title: The Onpattro story and the clinical translation of nanomedicines containing nucleic acid-based drugs publication-title: Nat Nanotechnol doi: 10.1038/s41565-019-0591-y – volume: 51 start-page: 8529 issue: 34 year: 2012 ident: 10.1016/j.dmpk.2022.100450_bib14 article-title: Maximizing the potency of siRNA lipid nanoparticles for hepatic gene silencing in vivo publication-title: Angew Chem Int Ed Engl doi: 10.1002/anie.201203263 – volume: 182 start-page: 1271 issue: 5 year: 2020 ident: 10.1016/j.dmpk.2022.100450_bib35 article-title: A Thermostable mRNA vaccine against COVID-19 publication-title: Cell doi: 10.1016/j.cell.2020.07.024 – volume: 148 start-page: 33 issue: 1–2 year: 2012 ident: 10.1016/j.dmpk.2022.100450_bib51 article-title: Lineage tracing publication-title: Cell doi: 10.1016/j.cell.2012.01.002 – volume: 5 start-page: 179 issue: 2 year: 2021 ident: 10.1016/j.dmpk.2022.100450_bib130 article-title: In vivo cytidine base editing of hepatocytes without detectable off-target mutations in RNA and DNA publication-title: Nat Biomed Eng doi: 10.1038/s41551-020-00671-z – volume: 107 start-page: 1864 issue: 5 year: 2010 ident: 10.1016/j.dmpk.2022.100450_bib18 article-title: Lipid-like materials for low-dose, in vivo gene silencing publication-title: Proc Natl Acad Sci USA doi: 10.1073/pnas.0910603106 – volume: 6 issue: 30 year: 2020 ident: 10.1016/j.dmpk.2022.100450_bib48 article-title: Neurotransmitter-derived lipidoids (NT-lipidoids) for enhanced brain delivery through intravenous injection publication-title: Sci Adv doi: 10.1126/sciadv.abb4429 – volume: 8 start-page: 677 issue: 9 year: 2001 ident: 10.1016/j.dmpk.2022.100450_bib39 article-title: Interaction between DNA-cationic liposome complexes and erythrocytes is an important factor in systemic gene transfer via the intravenous route in mice: the role of the neutral helper lipid publication-title: Gene Ther doi: 10.1038/sj.gt.3301460 – volume: 115 start-page: E3351 issue: 15 year: 2018 ident: 10.1016/j.dmpk.2022.100450_bib30 article-title: Successful reprogramming of cellular protein production through mRNA delivered by functionalized lipid nanoparticles publication-title: Proc Natl Acad Sci USA – volume: 294 start-page: 185 year: 2019 ident: 10.1016/j.dmpk.2022.100450_bib65 article-title: Pharmacokinetic evaluation of liposomal nanoparticle-encapsulated nucleic acid drug: a combined study of dynamic PET imaging and LC/MS/MS analysis publication-title: J Contr Release doi: 10.1016/j.jconrel.2018.12.006 – volume: 33 issue: 23 year: 2021 ident: 10.1016/j.dmpk.2022.100450_bib139 article-title: mRNA delivery of a bispecific single-domain antibody to polarize tumor-associated macrophages and synergize immunotherapy against liver malignancies publication-title: Adv Mater doi: 10.1002/adma.202007603 – volume: 5 start-page: 496 issue: 4 year: 2008 ident: 10.1016/j.dmpk.2022.100450_bib82 article-title: Pharmacokinetics and biodistribution of nanoparticles publication-title: Mol Pharm doi: 10.1021/mp800049w – volume: 339 start-page: 823 issue: 6121 year: 2013 ident: 10.1016/j.dmpk.2022.100450_bib102 article-title: RNA-guided human genome engineering via Cas9 publication-title: Science doi: 10.1126/science.1232033 – volume: 15 start-page: 6709 issue: 4 year: 2021 ident: 10.1016/j.dmpk.2022.100450_bib44 article-title: Apolipoprotein E binding drives structural and compositional rearrangement of mRNA-containing lipid nanoparticles publication-title: ACS Nano doi: 10.1021/acsnano.0c10064 – volume: 40 start-page: 89 issue: 1–2 year: 1999 ident: 10.1016/j.dmpk.2022.100450_bib93 article-title: Possibility of active targeting to tumor tissues with liposomes publication-title: Adv Drug Deliv Rev doi: 10.1016/S0169-409X(99)00042-3 – volume: 59 start-page: 357 issue: 5–6 year: 2003 ident: 10.1016/j.dmpk.2022.100450_bib55 article-title: Positron emission tomography microdosing: a new concept with application in tracer and early clinical drug development publication-title: Eur J Clin Pharmacol doi: 10.1007/s00228-003-0643-x – volume: 13 start-page: 214 issue: 3 year: 2018 ident: 10.1016/j.dmpk.2022.100450_bib77 article-title: A modular platform for targeted RNAi therapeutics publication-title: Nat Nanotechnol doi: 10.1038/s41565-017-0043-5 – volume: 36 start-page: 892 issue: 6 year: 2013 ident: 10.1016/j.dmpk.2022.100450_bib22 article-title: The polyethyleneglycol dilemma: advantage and disadvantage of PEGylation of liposomes for systemic genes and nucleic acids delivery to tumors publication-title: Biol Pharm Bull doi: 10.1248/bpb.b13-00059 – volume: 63 start-page: 494 issue: 7 year: 2011 ident: 10.1016/j.dmpk.2022.100450_bib54 article-title: Impact of microdosing clinical study - why necessary and how useful? publication-title: Adv Drug Deliv Rev doi: 10.1016/j.addr.2010.09.010 – volume: 118 issue: 10 year: 2021 ident: 10.1016/j.dmpk.2022.100450_bib118 article-title: Lipid nanoparticle-mediated codelivery of Cas9 mRNA and single-guide RNA achieves liver-specific in vivo genome editing of Angptl3 publication-title: Proc Natl Acad Sci USA doi: 10.1073/pnas.2020401118 – volume: 19 start-page: 191 issue: 3 year: 2002 ident: 10.1016/j.dmpk.2022.100450_bib41 article-title: Factors affecting drug and gene delivery: effects of interaction with blood components publication-title: Crit Rev Ther Drug Carrier Syst doi: 10.1615/CritRevTherDrugCarrierSyst.v19.i3.10 – volume: 339 start-page: 819 issue: 6121 year: 2013 ident: 10.1016/j.dmpk.2022.100450_bib101 article-title: Multiplex genome engineering using CRISPR/Cas systems publication-title: Science doi: 10.1126/science.1231143 – volume: 11 issue: 477 year: 2019 ident: 10.1016/j.dmpk.2022.100450_bib140 article-title: Durable anticancer immunity from intratumoral administration of IL-23, IL-36γ, and OX40L mRNAs publication-title: Sci Transl Med doi: 10.1126/scitranslmed.aat9143 – volume: 11 start-page: 3232 issue: 1 year: 2020 ident: 10.1016/j.dmpk.2022.100450_bib120 article-title: Systemic nanoparticle delivery of CRISPR-Cas9 ribonucleoproteins for effective tissue specific genome editing publication-title: Nat Commun doi: 10.1038/s41467-020-17029-3 – volume: 11 start-page: 8760 issue: 18 year: 2019 ident: 10.1016/j.dmpk.2022.100450_bib42 article-title: The role of surface chemistry in serum protein corona-mediated cellular delivery and gene silencing with lipid nanoparticles publication-title: Nanoscale doi: 10.1039/C8NR09855G – volume: 4 start-page: 467 issue: 4 year: 1998 ident: 10.1016/j.dmpk.2022.100450_bib62 article-title: In vivo imaging of oligonucleotides with positron emission tomography publication-title: Nat Med doi: 10.1038/nm0498-467 – volume: 7 start-page: 1 year: 2018 ident: 10.1016/j.dmpk.2022.100450_bib68 article-title: Testing thousands of nanoparticles in vivo using DNA barcodes publication-title: Curr Opin Biomed Eng doi: 10.1016/j.cobme.2018.08.001 – volume: 8 start-page: 2281 issue: 11 year: 2013 ident: 10.1016/j.dmpk.2022.100450_bib104 article-title: Genome engineering using the CRISPR-Cas9 system publication-title: Nat Protoc doi: 10.1038/nprot.2013.143 – volume: 353 start-page: aaf8729 issue: 6305 year: 2016 ident: 10.1016/j.dmpk.2022.100450_bib109 article-title: Targeted nucleotide editing using hybrid prokaryotic and vertebrate adaptive immune systems publication-title: Science doi: 10.1126/science.aaf8729 – volume: 102 start-page: 8369 issue: 23 year: 2005 ident: 10.1016/j.dmpk.2022.100450_bib74 article-title: Use of DNA barcodes to identify flowering plants publication-title: Proc Natl Acad Sci USA doi: 10.1073/pnas.0503123102 – volume: 361 start-page: 866 issue: 6405 year: 2018 ident: 10.1016/j.dmpk.2022.100450_bib106 article-title: CRISPR-Cas guides the future of genetic engineering publication-title: Science doi: 10.1126/science.aat5011 – volume: 63 start-page: 152 issue: 3 year: 2011 ident: 10.1016/j.dmpk.2022.100450_bib21 article-title: A multifunctional envelope type nano device (MEND) for gene delivery to tumours based on the EPR effect: a strategy for overcoming the PEG dilemma publication-title: Adv Drug Deliv Rev doi: 10.1016/j.addr.2010.09.001 |
SSID | ssj0033542 |
Score | 2.5077057 |
SecondaryResourceType | review_article |
Snippet | Lipid nanoparticles (LNPs) are becoming popular as a means of delivering therapeutics, including those based on nucleic acids and mRNA. The mRNA-based... |
SourceID | pubmedcentral proquest pubmed crossref elsevier |
SourceType | Open Access Repository Aggregation Database Index Database Enrichment Source Publisher |
StartPage | 100450 |
SubjectTerms | Base editing COVID-19 - therapy DNA barcode Gene Editing Humans Ionizable lipid Lipid nanoparticle Lipids Liposomes mRNA Nanoparticles Nucleic acid Positron emission tomography Recombination Review RNA, Messenger - genetics Targeting |
Title | Recent advances in lipid nanoparticles for delivery of nucleic acid, mRNA, and gene editing-based therapeutics |
URI | https://dx.doi.org/10.1016/j.dmpk.2022.100450 https://www.ncbi.nlm.nih.gov/pubmed/35381574 https://www.proquest.com/docview/2647654392 https://pubmed.ncbi.nlm.nih.gov/PMC9363157 |
Volume | 44 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3fb9MwED5t3QsviN-UwXRIaC_UahM7TvJYTYwCoppgk_oWJbEtAp1b0e2h__3uGqdbAe2BxyR2ZPnsuy-57z4DvKvJpjVFEmEjmwuVqURUtnLCSKXLpFLZyPL_jq9TPblQn2fJbA9OuloYplUG39_69I23DneGYTaHy6YZfuciSCV1GsebfJzeh4OYouuoBwfjT18m084hS5lsztDh9oI7hNqZluZlLpe_6DMxjpkvoLj8_t_x6W_8-SeN8k5cOn0EDwOgxHE75sewZ_0TOD5rFanXAzy_LbBaDfAYz261qtdPwRNspPdioAKssPE4b5aNQV96-p4OtDkkaIvGzpnEscaFQ88yyE2NZd2YAV5-m44HWHqDtBwt0pwymVpwhDR4p8Jr9QwuTj-cn0xEOIJB1HzSgdAZ4SXOjeaV1s6YqBzlmZNSW4JZzkUuSq2KyrIypmStPxbbIUDkqrgmj05Q4jn0_MLbl4B5ZjLDicfIEWoj4GgzziZnLifEmMRVH6Ju4os66JPzMRnzoiOi_SzYWAUbq2iN1Yf32z7LVp3j3tZJZ89iZ40VFD7u7fe2M35Bm48zKqW3i-tVQWgy5eLcPO7Di3YxbMchKZRESar6kO4sk20DFvbefeKbHxuB71xqSV1f_ed4D-EBX7WEttfQu_p9bd8QdLqqjsLWOIL9j7PoButVGF8 |
linkProvider | Elsevier |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1NbxMxELWq9gAXxDcBCoMEvZBVuvZ-HnqIgCohbVRBKvVmvGtbLKROxLZC-V39g53JetMGUA9Iva7XK8tjzzzvvHlm7G2JNi0xkgQmNHkQZVEcFKawgRZRouIiynYN_e84HCeD4-jzSXyywS7aWhiiVXrf3_j0pbf2T3p-Nnvzqup9pSLISCQp58t8XOKZlSOz-I3ntnpv-BGN_I7z_U-TD4PAXy0QlKTgHyQZ4gDK-eVFklitQ7WbZ1aIxCB8sDa0YWqiUKlCa0UadiQig4HeFrxET8VJgQn9_hapYeG22uoPR4NxGwCEiJd39tD4Ahqgr9VpaGX6dP4Tj6WcEz8honL_f8fDv_Hun7TNa3Fw_z675wEs9Js5esA2jHvIdo4aBexFFyZXBV11F3bg6Eobe_GIOYSp-F3w1IMaKgfTal5pcMrh-d3T9AChNGgzJdLIAmYWHMkuVyWostJdOP0y7ndBOQ24_A2gDYm8HVBE1nCtoqx-zI5vxS5P2KabOfOMQZ7pTFOiM7SIEhGomoyy15nNEaHGvOiwsJ14WXo9dLqWYypb4tsPScaSZCzZGKvD3q_6zBs1kBvfjlt7yrU1LTFc3djvTWt8iZudMjjKmdl5LRG9plQMnPMOe9oshtU4BIauME6jDkvXlsnqBRISX29x1feloHguEoFdn__neF-zO4PJ4YE8GI5HL9hdamnIdC_Z5tmvc7ONsO2seOW3CbBvt70zLwF97VPp |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Recent+advances+in+lipid+nanoparticles+for+delivery+of+nucleic+acid%2C+mRNA%2C+and+gene+editing-based+therapeutics&rft.jtitle=Drug+metabolism+and+pharmacokinetics&rft.au=Mukai%2C+Hidefumi&rft.au=Ogawa%2C+Koki&rft.au=Kato%2C+Naoya&rft.au=Kawakami%2C+Shigeru&rft.date=2022-06-01&rft.pub=The+Japanese+Society+for+the+Study+of+Xenobiotics.+Published+by+Elsevier+Ltd&rft.issn=1347-4367&rft.eissn=1880-0920&rft.volume=44&rft.spage=100450&rft.epage=100450&rft_id=info:doi/10.1016%2Fj.dmpk.2022.100450&rft_id=info%3Apmid%2F35381574&rft.externalDocID=PMC9363157 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1347-4367&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1347-4367&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1347-4367&client=summon |